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Enantioselective, Bronsted Acid-Catalyzed Addition of Carbon and Nitrogen 
 
Nucleophiles to Imines 
 
Gerald B. Rowland Jr. 
 
ABSTRACT 
 
 The development of enantioselective reaction methodology has been at the 
forefront of research in both academic and industrial research laboratories due to the 
importance of chiral molecules in biological systems.  An emerging area of research in 
the development of enantioselective reaction methodology has been the development of 
organocatalytic reactions.  Organocatalysis, the use of small, chiral organic molecules as 
catalysts, has the advantage over traditional Lewis acid catalysis in that the reactions in 
general produce less toxic by-products.  One recent breakthrough in the development of 
enantioselective methodology has been the development of chiral phosphoric acids as 
organocatalysts.  Chiral phosphoric acids have been shown to be excellent catalysts for a 
wide variety of reactions.  In this thesis chiral phosphoric acid-catalyzed enantioselective 
reaction methodologies have been developed for the addition of sulfonamides and indoles 
to imines. 
 The development of Bronsted acid-catalyzed amidation of imines allows for an 
expedient route for the synthesis of N,N-aminals, which have been incorporated into a 
wide variety of biologically active compounds.  Initial studies were undertaken to 
determine the practicality of a Bronsted acid-catalyzed method for the addition of amides 
xii 
to N-Boc protected imines.  Over 20 achiral Bronsted acids were screened, and it was 
found that phenylphosphinic acid and trifluoromethanesulfinimide were both excellent 
catalysts for the addition of amides to a variety of imines giving the respective products 
in excellent yield.  The methodology was extended to the development of an 
enantioselective method for the addition of sulfonamides to imines.  It was found that a 
chiral phosphoric acid derived from the VAPOL ligand was suitable for this purpose.  
The developed methodology is capable of tolerating a wide variety of functional groups 
allowing for the preparation of the N, N-aminal products in excellent yield and 
enantioselectivities. 
 An enantioselective phosphoric acid-catalyzed aza-Friedel-Crafts reaction 
between N-benzylindoles derivatives and N-benzoyl protected imines has been 
developed.  A catalyst derived from the BINOL backbone was found to be the optimum 
catalyst for the enantioselective transformation.  The developed methodology was 
capable of tolerating a wide variety of functional groups and provides an expedient route 
for the synthesis of chiral 3-indolylmethanamines.   
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Chapter 1 
Organocatalytic, Enantioselective Additions of Nucleophiles to C—O and C—N  
Double Bonds 
 Due to the handedness of the molecules of life, such as amino acids and DNA, 
enantiomeric compounds often display vastly different biological activities.1 A few 
examples of the different biological activity of enantiomeric compounds are the 
pharmaceutical compounds ibuprofen and thalidomide.2 In the case of ibuprofen, the (S)-
enantiomer was found to be active in both in vitro and in vivo testing.  The (R)-
enantiomer of ibuprofen has been shown to have none of the beneficial biological activity 
that is exhibited by the (S)-enantiomer.  A recent survey of several pharmaceutical 
companies showed that 54% of the new drug candidates in development contain at least 
one chiral center, and all but two of the drug candidates are being developed as 
enantiomerically pure compounds.3 Due to the common difference in biological activity 
of enantiomeric compounds, the development of methods for the synthesis of 
enantiomerically pure compounds has been at the forefront of research in many industrial 
and academic research laboratories.  At the present time, the most commonly used 
methods for the synthesis of enantiopure compounds are employing the chiral pool, chiral 
auxiliaries, resolution, and enantioselective catalysis.  The development of catalytic, 
enantioselective reaction methodologies has a major advantage over the other methods 
that are currently used in that only a catalytic amount of the chiral reagent is required for 
the synthesis of enantiopure compounds.4   
2 
 Until the late 1990’s, the major research development of catalytic enantioselective 
reaction methodology focused on the employment of chiral metal complexes.  Chiral 
Lewis acids had the major advantage of employing substoichiometric amounts of the 
often expensive chiral ligand.  The development of such reaction methodology was not 
without its drawbacks.  The major drawback of such enantioselective methodologies was 
the production of often toxic metal by-products.  Due to this disadvantage and ever-
tightening FDA guidelines, researchers looked to develop new catalytic reaction 
methodologies that did not require the use of chiral metal complexes for enantioselective 
conversions.  This area of asymmetric catalysis has become commonly known as 
organocatalysis.  Asymmetric organocatalysis is the use of small, chiral organic 
molecules as catalysts for enantioselective transformations.5   
 Asymmetric organocatalysis traces its roots back to work reported about one 
hundred years ago.  In 1912, Bredig and Fiske reported that the addition of hydrogen 
cyanide to benzaldehyde was accelerated by the presence of the alkaloids quinine and 
quinidine.6 The resulting cyanohydrin products were found to be formed in an optically 
active form.  The optical purity of the products formed from this transformation was 
found to be less than 10%.  In 1960, Pracejus and co-workers reported the 
enantioselective addition of methanol to phenylmethylketene 1 employing only 1 mole 
percent of O-acetylquinine 3 as the catalyst.  The resulting ester 2 was formed in 74% ee 
(Figure 1.1).7 
 Over the last decade, there has been an increased interest in the development of 
enantioselective, organocatalytic reactions.  During this time period several different 
classes of organocatalysts have been reported in the literature.  The major classes of 
3 
organocatalyst that have been reported in the literature can be divided into enamine 
catalysts, iminium catalysts, and hydrogen-bonding catalysts. 
 
 
 
 
 
Figure 1.1.  Alkaloid-Catalyzed Addition of Methanol to Ketenes 
1.1 Enamine Catalysis 
 Enamine catalysis involves the use of chiral primary or secondary amines as 
catalysts for the addition of electrophiles to the α-position of a carbonyl compound 
(Figure 1.2).8 The reactions proceed through an enamine intermediate.  The formation of 
the initial iminium ion results in a decrease in the energy of the LUMO of the carbonyl 
compound as well as increased acidity of the α-proton.  This increased acidity of the α-
proton results in the loss of the α-proton and the formation of an enamine.  The enamine 
then acts as a nucleophile adding to an electrophilic C—O or C—N double bond.  This 
resulted in the formation of a new iminium ion intermediate, which readily undergoes 
hydrolysis to give the final product 10. 
 
 
O
Me
Ph
Catalyst 3 (1 mol%)
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Figure 1.2.  Catalytic Cycle for Enamine Catalysis 
 The first report of enantioselective enamine catalysis was in 1974. Parrish and co-
workers reported that a catalytic amount of L-proline was able to catalyze the Robinson 
annulation providing the product 13 in quantitative yield and 93% ee (Figure 1.3).9  This 
chemistry was rooted deeply in the work reported by Stork involving preformed, chiral 
enamines for diastereoselective synthesis.10 The reaction became known as the Hajos-
Parrish-Elder-Sauer-Wiechert reaction.  The reaction allowed for an expedient, 
enantioselective route for the enantioselective synthesis of a variety of important 
synthetic intermediates, including the Wieland-Mischler ketone 14. 
N
H
R1
R2
O
R1
R2
N
R1
R2
N
O
R3
OH
R3
N
R1
R2
H2O
O
R1 R3
OH
R2
4
5
6
7
8
9
10
5 
Figure 1.3.  Proline-Mediated Robinson Annulation  
 It took more than twenty years for the next major breakthrough in enamine 
catalysis to occur.  In 2000, inspired by the work of Barbas and Lerner on Class I 
aldolase enzymes11, List and co-workers reported the application of proline as a catalyst 
for the first organocatalytic, intermolecular aldol reaction between aldehydes and ketones 
(Table 1.1).12  The reaction required catalyst loadings between 10 and 30 mole percent 
and provided the aldol adducts 17a-f in enantioselectivities from 72% ee to greater than 
99% ee. In the cases where the formation of diastereomers was possible, the system 
favored the formation of the anti-diastereomer. 
Table 1.1.  Proline-Catalyzed Intermolecular Aldol Reaction 
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R2
+
O
H R3
O
R1 R3
OH
R2
O OH O OH O OH
O OH
O OH OHO
62% Yield
72% ee
97% Yield
96% ee
85% Yield
>99% ee
34% Yield
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84% ee
77% Yield
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3:1 dr
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10-30 mol%
DMSO or DMF
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17e 17f
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30 mol%
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O
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Me
100% yield
93% ee
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 Soon after the initial report of the enantioselective cross-aldol reaction, List and 
co-workers reported the proline-catalyzed enantioselective Mannich reaction (Table 
1.2).13 The reaction was a one-pot, three-component reaction involving a ketone, an 
aldehyde, and an amine.  The reaction employed 20 mol % of (S)-proline as a catalyst and 
resulted in the formation chiral amines 19a-e in excellent enantioselectivity.  Where as 
the proline-catalyzed aldol reaction favored the formation of the anti-diastereomer, the 
proline-catalyzed Mannich reaction favored the formation of the syn-diastereomer.  The 
reaction conditions were able to tolerate a wide variety of ketones allowing for the 
synthesis of highly functionalized amines.  An example of this is the use of α-hydroxy 
ketones as the nucleophiles.  The developed methodology allowed for the direct synthesis 
of α-amino alcohols. 
Table 1.2.  List’s Proline-Catalyzed Three-Component Mannich Reaction 
O
R1
R2
+
O
H R3
+
H2N
OMe
O
R1
R2
HN
R3
OMe
(S)-Proline
5-35 mol%
DMSO
O HN
OMe
O HN
OMe
O HN
OMe
O
OH
HN
OMe
O
OH
HN
OMe
35% yield, 96% ee 90% yield, 93% ee 74% yield, 73% ee
8% yield, 61% ee
9:1 dr
57% yield, 65% ee
17:1 dr
15 16
18
19a-e
19a 19b 19c
19d 19e
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 Soon after the initial report by List and co-workers, Barbas and co-workers 
independently reported the proline-catalyzed one-pot, three-component Mannich reaction 
(Table 1.3).14 Similar to List, the Mannich reaction reported by Barbas required high 
catalyst loadings, some up to 35 mol % of proline.  The reaction scope was found to be 
broader than the initial report by List.  The reaction was able to tolerate more diverse 
functionality on the ketone component of the reaction.  It is also worth noting that the 
reaction conditions provided the thermodynamically favored product when sterically less 
demanding aldehydes were employed.  In cases where sterically more demanding 
substituents are present on the aldehyde, the reaction favored the product derived from 
the kinetically favored enamine.  This selectivity is mainly due to steric repulsion. 
Table1.3.  Barbas’s Proline-Catalyzed Three-Component Mannich Reaction 
 
O
R2
+
O
H R3
+
H2N
OMe
O
R2
HN
R3
OMe
(S)-Proline
5-35 mol%
DMSO
O HN
OMe
O HN
OMe
O HN
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O
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O
OH
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O HN
OMe
OBn
88% yield, 95% ee 66% yield, dr >19:1,
 98% ee
30% yield, dr >19:1, 
90% ee
46% yield,dr >20:1, 
94% ee
70% yield, dr >20:1,
 91% ee
74% yield, dr >20:1,
 93% ee
R1
R1
NO2
OBn
20 16 18 21a-f
21a 22b 21c
21d 21e 21f
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 The initial reports by the List and Barbas have paved the way for the application 
of enamine catalysis to a wide variety of systems.8 Enamine catalysis has now been 
shown to be an excellent platform for enantioselective Michael addition reactions and α-
functionalization of carbonyl compounds, as well as others.15,16  New catalysts have led to 
the development of new enantioselective methodology that require a much lower catalyst 
loading than the initial reports by Barbas and List. 
1.2.  Iminium Catalysis 
Iminium catalysis, like enamine catalysis, employs a chiral primary or secondary 
amine as a catalyst.17 In the case of iminium catalysis, however, the catalyst activates the 
carbonyl, which in turn acts as an electrophile rather than a nucleophile as is the case 
with enamine catalysis.  Chiral secondary amines have been the primary choice of 
catalyst due to the fact that a co-catalyst is not required for iminium ion formation.  The 
resulting iminium ions are more electrophilic than either the corresponding aldehyde or 
ketone. Iminium catalysts have been widely used for the activation of α,β-unsaturated 
systems (Figure 1.4).  The first step of the mechanism involves the reaction of the amine 
catalyst 4 with the carbonyl compound 22 resulting in the formation of the iminium ion 
23.  This type of activation lowers the energy of the LUMO of the carbonyl system.  The 
addition of the nucleophile to the activated system, followed by hydrolysis of the 
iminium provides product 26 and recovery of the amine catalyst.  It is important to note 
that each of the different types of iminium catalyzed reactions, other than the 
cycloaddition reactions, were reported in some form prior to 1940. 
 
9 
 
 
 
 
 
 
 
 
 
 
Figure 1.4.  Catalytic Cycle for Iminium Activation 
The earliest recorded example of a reaction being catalyzed by an iminium ion is 
the Knoevenagal condensation.18 After the initial report by Knoevenagal in 1894, it took 
35 years for Blanchard and co-workers to suggest that positive ions play a role in the 
secondary amine-mediated Knoevenagal condensation.19 It was not until 1951 that 
Crowell and Peck discovered experimental evidence for the involvement of the iminium 
ion.20 Today the role of the iminium ion in the Knoevenagal condensation is widely 
recognized. 
The first report of the use of a chiral secondary amine in an iminium ion-mediated 
reaction was by Woodward and co-workers in 1981 (Figure 1.5).21 The researchers 
reported the use of stoichiometric amounts of D-proline for the deracemization of a 
thianone intermediate in route to the synthesis of erythromycin.  The reaction first 
involves the formation of an enamine, followed by elimination of a sulfide to form  
N
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10 
α,β−unsaturated iminium ion 28.  The sulfide ion then adds to the iminium ion in a 
Michael fashion.  The resulting enamine intermediate 28 then undergoes an 
intramolecular aldol reaction resulting in the formation of bicyclic product 29. 
 
Figure 1.5.  Woodward’s Proline-Mediated Deracemization of Thianone in Route to 
the Synthesis Erythromycin 
 The first catalytic, enantioselective iminium ion-mediated reaction was reported 
in 1991.  Yamaguchi and co-workers reported the proline-catalyzed conjugate addition of 
malonate esters to α,β-unsaturated aldehydes.22 The reaction gave the product in 
enantioselectivities ranging from to 35 to 77% ee.  
 The next major breakthrough in enantioselective iminium catalysis was the 
development of imidizolidinone catalysts by MacMillan and co-workers.23 MacMillan 
and co-workers first reported the use of catalysts containing the imidizolidinone 
backbone for the first highly-enantioselective Diels-Alder reaction (Table 1.4).24 The 
reaction involved the enantioselective addition of both cyclic and acyclic dienes to α,β-
unsaturated aldehydes. The criteria that the MacMillan group felt were important for an 
excellent iminium ion catalyst were the rate of iminium ion formation, control of the 
iminium ion geometry, selective discrimination of the olefin π-face, and ease of catalyst 
preparation.  With these critical factors in mind, computational and kinetics studies led to 
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HH
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27 28 29
11 
the conclusion that catalyst based upon the imidizolidinone scaffold should be efficient 
iminium ion catalysts.  The enantioselective Diels-Alder reaction of cyclopentadiene with 
α,β-unsaturated aldehydes provided the products in excellent yield and enantioselectivity, 
however the ratio of endo to exo product formed was only 1:1.  The use cyclohexadiene 
as the diene resulted in a marked increase in endo:exo ratio of the product, up to 14:1 in 
favor of the endo product, while similar yields and enantioselectivities to the reactions 
employing cyclopentadiene as the diene 
Table 1.4.  Imidizolidinone-Catalyzed Enantioselective Diels-Alder Reaction 
 
 
 Computational studies indicated that the iminium ion-catalyzed Diels-Alder 
reaction followed an asynchronous mechanism rather than the traditionally accepted 
R1
R4
R3
R2 CHO
R5
R1
R4
R2
R3
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R5
Me
CHO CHO
MePh OAc
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Me
CHO
CHOPr
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Ph
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Me
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Me
N
H
N
O
Ph
Me
20 mol%
MeOH-H2O
23 oC, 3-24 h
75% Yield
1:1 Endo:Exo
90% ee
99% Yield
1:1.3 Endo:Exo
93% ee
92% Yield
1:1 Endo:Exo
90% ee
82% Yield
14:1 Endo:Exo
94% ee
84% Yield
89% ee
75% Yield
90% ee
75% Yield
5:1 Endo:Exo
90% ee
72 % Yield
11:1 Endo:Exo
85% ee
30 31
32
33a-h
33a 33b 33c 33d
33e 33f 33g 33h
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concerted mechanism where the rate-limiting step was attack of the diene on the β-carbon 
of the iminium ion.  The selectivity of the reaction was believed to be controlled by a π−π 
interaction between the benzyl group of the catalyst and π-system of the iminium ion.  
The imidazolidinone catalysts have been shown to be excellent catalyst for a wide-range 
of enantioselective transformations including aldol reactions25 and α-halogenation of 
aldehydes26, as well as the use of the application of cascade reactions as the key step on 
the synthesis of several natural products.27 
Table 1.5.  Counterion-Catalyzed Reduction of α ,β-Unsaturated Aldehydes 
 
 A new approach to the development of enantioselective, iminium-ion catalyzed 
reaction methodology is the use of chiral counterions in association with an amine 
catalyst.  List and co-workers were the first to report such a strategy for the 
enantioselective reduction of α,β−unsaturated aldehydes (Table 1.5).28 In the initial 
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20 mol% 35
Dioxane, 50 oC, 24 hAr
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CHO CHO
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87% Yield
96 % ee
84% Yield
98 % ee
90% Yield
98 % ee
72% Yield
99% ee
63% Yield
98% ee
34
35
36
37a-g
37a 37b
37c
37e 37f
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report, morpholine salt 35 of a chiral phosphoric acid derived from BINOL was found to 
be an excellent catalyst for the enantioselective reduction employing Hantzsch ester 
derivative 36 as the reducing agent.  A wide variety of aromatic substituted 
α,β−unsaturated aldehydes were tolerated by the catalyst system.  All reactions provided 
aldehyde products in excellent yields and enantioselectivities. 
1.3.  Hydrogen Bonding Catalysis 
 Hydrogen bonding interactions make up a class of vitally important interactions in 
nature.29 Such interactions are responsible for the double-helix structure of DNA as well 
as the binding of many pharmaceutical agents to the active site of proteins.  Hydrogen 
bonds are also responsible for the secondary and tertiary structures of proteins.  The 
origin of hydrogen bonding can be traced back to the early 1900’s where hydrogen bonds 
were observed in several chemical systems.30 It was not until 1931 that the term 
“hydrogen bond” was first proposed by Linus Pauling in his studies into the structure of 
the chemical bond.31 Prior to this report, hydrogen bonds were referred to as “inner 
complex building”, “weak union”, and “chelation”.  Unlike covalent bonds, bond angles, 
bond distances, and energy distributions can vary greatly in hydrogen-bonded systems, 
even within the same bonding partners. 
 Hydrogen bonding catalysis can trace it roots back to alkaloid catalyzed conjugate 
addition reactions.  In 1981, Wynberg and co-workers reported the enantioselective 
addition of thiols to α,β-unsaturated ketones catalyzed by quinine, quinidine, cinchonine, 
and cinchonidine.32 Each of these alkaloids contains a free hydroxyl group in close 
proximity to the basic quinuclidine nitrogen.  The use 1 mol % of the alkaloid catalyst 
allowed for the synthesis of the product in up to 75% ee. 
14 
1.3.1.  Chiral Thiourea Catalysis 
 While the initial reports of hydrogen-bonding catalysis was reported in the early 
1980’s, it was not until 1998 that the practical application of chiral hydrogen-bonding 
catalysts was first reported by Jacobsen and co-workers (Table 1.6).33 During the 
screening of a library of chiral ligands for the aluminum-catalyzed addition of hydrogen 
cyanide to imines, also known as the Strecker reaction, it was discovered that chiral urea 
and thiourea compounds were capable of catalyzing the reaction. The developed 
methodology gave the product in both excellent yield and enantioselectivity for both 
aromatic and aliphatic substituted imines.   
Table 1.6.  Thiourea-Catalyzed Enantioselective Strecker Reaction 
 
 Since the initial report, chiral urea and thiourea catalysts have been shown to be 
excellent catalysts for the addition of a wide range of nucleophiles, including the 
enantioselective additions of nitroalkanes and silyl ketene acetals, to imines.34,35 The 
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78% Yield
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92% Yield
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65% Yield
86% ee
88% Yield
88% ee
70% Yield
85% ee
77% Yield
83% ee
1)  2 mol% 39, 
     toluene, -70 oC, 20 h
2)  TFAA
38
40a-f
39
40a 40b 40c
40d 40e 40f
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mechanism for the reaction first involves the formation of hydrogen bonds between the 
catalyst and the electrophile (Figure 1.6).  The thiourea catalyst was found to form two 
hydrogen bonds with the electrophile.  The formation of two hydrogen bonds between the 
electrophile and the catalyst allows for the formation of a rigid chiral intermediate.  It was 
also found to be important that the catalyst is substituted with groups that are capable of 
secondary interactions with the reactants. 
 
 
 
 
 
 
 
Figure 1.6.  Mechanism for Activation of Electrophile by Thiourea Catalysts 
 Thiourea-derived catalysts have also been shown to be excellent catalyst for a 
variety of cyclization reactions.  In 2004, Jacobsen and co-workers reported the 
application of a chiral thiourea catalyst for the enantioselective N-acyl Pictet-Spengler 
reaction (Table 1.7).36 The reaction involved the activation of an imine derived from 
tryptamine with acetyl chloride.  The thiourea catalyst was believed to hydrogen bond to 
the N-acyl group to help activate the iminium ion.  The resulting tetrahydro-β-carboline  
products were formed in high yield and excellent ee when the imines were derived from 
aliphatic aldehydes.  The use of aromatic substituted imines was not reported. 
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Table 1.7.  Thiourea-Catalyzed N-Acyl Pictet-Spengler Reaction. 
  
 Jacobsen and coworkers reported that chiral thiourea catalysts were capable of 
catalyzing the Pictet-Spengler reaction of hydroxylactams.37 The developed methodology 
was capable of synthesizing both chiral indolizidinones and quinolizidinones in both 
excellent yields and enantioselectivities.  The reaction involves the conversion of 
hydroxy group of hydroxylactams to a chloride with TMS-Cl.  The resulting halogenated 
compound is then treated with the thiourea catalyst.  This is believed to result in the 
formation of a chiral ion-pair, which then undergoes cyclization to form the resulting 
products (Figure 1.5) 
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Figure 1.7.  Mechanism of Pictet-Spengler Cyclization of Hydroxylactam 
 In 2008, Jacobsen and co-workers extended the use of thioureas as ion-pair 
catalysts to the enantioselective addition of silyl ketene acetals to oxocarbenium ions 
(Table 1.8).38 Such methodology had played a major role in the development of 
carbohydrate methodology; however, it had not been exploited in the development of 
enantioselective reaction methodology.  The oxocarbenium ions were generated by 
treatment of a α−chloroglycosyl compound with the chiral thiourea catalyst, resulting in 
the formation of a chiral ion-pair.  The silyl ketene acetal then adds to the generated 
oxocarbenium ion resulting in the formation of the ether in excellent yield and ee.  The 
reaction was capable of tolerating a variety of silyl ketene acetals. 
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Table 1.8.  Thiourea-Catalyzed Additions to Oxocarbenium Ions 
 
 Thiourea catalysts have had a broad impact on the development of 
organocatalytic, enantioselective reaction methodology.  Bedsides the reactions discussed 
here, thiourea catalysts have been used for the development of enantioselective Morita-
Bayliss-Hillman reaction, resolution of azalactones, and cyanosilylation of ketones, as 
well as many other reactions.29 
1.3.2.  Enantioselective Diol Catalysis 
 Chiral diols have had a long history in the development of enantioselective 
reaction methodology.4 Many diols had been employed as chiral ligands for the 
development of enantioselective, Lewis acid-catalyzed reaction methodology, most 
notably the application of tartrates by Sharpless and co-workers for the titanium catalyzed 
epoxidation of allylic alcohols.  It was not until 2003 that chiral diols were shown to be 
excellent catalysts for the development of enantioselective, organocatalytic reaction 
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methodology.  In that year, Rawal and co-workers reported the TADDOL catalyzed, 
enantioselective hetero-Diels-Alder reaction between aldehydes 16 and Kozmin’s diene 
56 (Table 1.9).39 The reaction was capable of tolerating a wide variety of substituents on 
the aldehyde.  The reaction resulted in the formation of the cycloadducts in good yields 
and excellent enantioselectivities.  Soon after the initial report, Rawal and co-workers 
reported that the BAMOL ligand was capable of catalyzing the same transformation. The 
BAMOL catalyst gave the product in higher yield than the reaction catalyzed by 
TADDOL with similar enantioselectivities.40 
Table 1.9.  TADDOL-Catalyzed Enantioselective Hetero-Diels-Alder Reaction 
 
 
 
 
 
 
 In 2003, Schaus and co-workers reported the enantioselective Morita-Baylis-
Hillman reaction between aldehydes and cyclic enones catalyzed by a chiral BINOL 
derivative (Table 1.10).41 The reaction gave the Baylis-Hillman adduct in excellent yield 
and enantioselectivity for aliphatic substituted aldehydes.  The presence of aromatic 
substituents on the aldehyde resulted in a decrease in both the yield and enantioselectivity 
of the resulting product.  It is also worth noting that when one of the phenol groups on the 
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catalyst is protected with a methyl group it results in a marked decrease in both the yield 
and enantioselectivity. 
Table 1.10.  BINOL-Catalyzed Morita-Baylis-Hillman Reaction 
 
 A few years after the initial report by Schaus, Sasai and co-workers reported the 
enantioselective aza-Morita-Baylis-Hillman reaction between N-tosyl imines and α,β-
unsaturated ketones (Table 1.11).42 The catalyst employed for the reaction was a BINOL 
derivative that had both the Bronsted acidic phenol groups and Lewis basic pyridine 
substituent.  This removes the need for a separate nucleophile that is required to activate 
the ketone.  Variation of the catalyst structure showed a marked difference in both the 
yield and the enantioselectivity of the product.  Removal of the electron-donating 
substituent on the pyridine ring resulted in no reaction.  It was also shown that protection 
of the phenol groups of the catalyst resulted in an inactive catalyst.  The conclusions that 
were drawn based upon the experimental data was that both the Bronsted acid and Lewis 
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basic components of the catalyst were required in order to obtain the products in excellent 
yields and enantioselectivities. 
Table 1.11.  Bifunctional Organocatalytic Aza-Morita-Bayliss-Hillman Reaction 
 
1.3.3.  Enantioselective Phosphoric Acid Catalysis  
 Bronsted acids have been shown to be excellent catalysts for a wide-variety of 
transformations such as acetal formation, esterification, and hydrolysis.43,44 It was not 
until recently, however, that the development of chiral Bronsted acids has been exploited 
as catalysts for enantioselective reactions.  While the chiral diols and Thiourea catalysts 
that have been previously discussed are considered to be Bronsted acid catalysts, they are 
considered to be neutral Bronsted acids that are generally associated with activation by 
hydrogen bonding.  While these catalysts have been shown to be excellent catalyst for a 
wide variety of transformations, many reactions require the use of Bronsted acids that are 
better proton donors.  The first report of an enantioselective transformations that 
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employed a stronger Bronsted acid was the aza-Henry reaction by Johnston and co-
workers in 2004 (Table 1.12).45 The researchers employed a chiral ammonium salt as a 
Bronsted acid catalyst.  The reaction provided the products resulting from the addition of 
nitroalkanes to N-Boc protected imines in excellent yields and enantioselectivities.  The 
reaction allows for the expedient synthesis of chiral, vicinal diamines.  Perrin titration 
studies on the catalyst led to the determination that the pKa of the catalyst was 5.74.46 
Table 1.12.  Ammonium Salt-Catalyzed Aza-Henry Reaction 
 
 In 2004, Akiyama and co-workers reported the use of a chiral phosphoric acid 
derived from BINOL for the development of an enantioselective Mannich reaction 
between silyl ketene acetals and imines (Table 1.13).47 The phosphoric acid catalyst are 
considered by some to be bifunctional in nature, containing both a Bronsted acidic 
hydrogen and a Lewis basic oxygen on the phosphoric acid.  The BINOL framework was 
employed as the chiral backbone due to the ease in which it may be modified in order to 
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tune both the electronics as well as the steric bulk of the catalyst.  The phosphoric acid 
that gave the best results in terms of both yield and enantioselectivity of the product was 
a BINOL phosphoric acid that was substituted in the 3 and 3’ positions with a p-
trifluoromethyl phenyl group.  The use of electron-donating aromatic substituents on 
these positions showed are marked decrease in both the enantioselectivity and yield of the 
resulting product.  The developed methodology allows for the synthesis of chiral β-amino 
acid derivatives.  The reported methodology tolerated a variety of substituents on both the 
imine and the silyl ketene acetal reactants. 
Table 1.13.  Akiyama’s Phosphoric Acid-Catalyzed Mannich Reaction 
 
 Soon after the initial report by Akiyama and co-workers, Terada and co-workers 
reported the Mannich reaction of acetylacetone with N-Boc protected imines catalyzed by 
a phosphoric acid catalyst derived from BINOL (Table 1.14).48 In this case, a catalyst 
with more sterically demanding substituents in the 3,3’ positions of BINOL were 
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required in order to provide the product in best yield and enantioselectivity.  The 
phosphoric acid that proved to be best for the reaction in terms of both yield and 
enantioselectivity had β−naphthyl-C6H4 substituents in the 3 and 3’ positions of BINOL.  
The reaction was able to tolerate a wide variety of aromatic substituents on the imine, all 
resulting in the formation of the product in greater than 94% yield and 92% ee.  The 
reaction employed 2 mol % of the chiral phosphoric acid, a decrease in the catalyst 
loading when compared to Akiyama’s Mannich reaction. 
Table 1.14.  Terada’s Phosphoric Acid-Catalyzed Mannich Reaction 
  
 The most widely accepted mechanism for the activation of imines with 
phosphoric acids has been the transfer of the proton from the catalyst to the imine 
nitrogen atom (Figure 1.8).  This results in the formation of a chiral ion pair which blocks 
one face of the imine from attack by the nucleophile.  The nucleophile then attacks the 
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open face of the imine, resulting in the formation of the product and reforming the acid 
catalyst so that it may go through the catalytic cycle again. 
 
 
 
 
 
 
Figure 1.8.  Catalytic Cycle of Imine Activation by Chiral Phosphoric Acids 
 Since the initial reports of the application of chiral phosphoric acids for the 
development of enantioselective reaction methodology, several other research groups 
have shown that chiral phosphoric acids may be employed as catalysts for a variety of 
enantioselective transformations.  These transformations include the addition of 
nucleophiles to imines, reduction of imines, reduction of imino esters, the Pictet-Spengler 
reaction, and various cycloaddition reactions.44  
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Chapter 2 
Enantioselective Bronsted Acid-Catalyzed Amidation of Imines 
 Imines have been shown to versatile intermediates for the development of 
enantioselective reaction methodology.4 The additions of nucleophiles to imines allows 
for the expedient synthesis of chiral amines.  Chiral amines play an important role in 
many biologically active compounds.  A recent survey of several pharmaceutical 
companies showed that approximately 90% of the new drug candidates contain at least 
one nitrogen atom.3 In the same survey, it was shown that 54% of the drug candidates in 
development contain at least one chiral center.  All but two of the drug candidates that 
were being developed were being synthesized as single enantiomers.  To date, the most 
common method utilized by the pharmaceutical companies for the synthesis of chiral 
compounds has been the resolution of racemic intermediates.  This method, while being 
the most dependable and cost efficient method to date, has many drawbacks when 
compared to catalytic, enantioselective reaction methodology.  It produces more waste 
than catalytic methodology and it also requires the use of stoichiometric amounts of 
often-expensive chiral reagents.  
 All of the previously reported enantioselective reactions involving the addition of 
nucleophiles to imines employed carbon nucleophiles to imines.  We envisioned the 
development of a new area of enantioselective reaction methodology employing 
heteroatom nucleophiles.  The first nucleophile that we focused our efforts on was amide 
27 
nucleophiles.  The resulting protected N,N-aminals had been shown to be biologically 
active when incorporated into peptide chains. 
2.1.  Retro-Inverso Peptide Mimics   
 In the late 1970’s, Goodman and co-workers reported the development of retro-
inverso peptide mimics (Figure 2.1).49 Rather than the typical manner in which peptides 
were assembled, Goodman and co-workers prepared peptides in which the orders of the 
peptide bonds were reversed.  Peptides such as 79 have been shown to have high levels of 
biological activity.  They have been shown to be somatostatins, glycosidase inhibitors, 
and have been incorporated into artificial sweeteners. 
 
 
 
Figure 2.1.  Retro-Inverso Peptide Mimics 
 Several methods were soon developed for the synthesis of the retro-inverso 
peptide mimics (Figure 2.2).  The earliest synthetic methods employed a Curtius 
rearrangement of isocyanates and Hofmman-type rearrangement using mild oxidizing 
agents.  This resulted in the synthesis of the aminal product in good yield.  Other 
synthetic methods for the synthesis of retro-inverso peptide mimics have been the 
amidoalkylation of thiols as well as the benzotriazole-mediated methodology developed 
by Katritzky and co-workers.50 While these methods are all capable of synthesizing a 
variety of N,N-aminals, they require multiple steps, some as many as four steps, harsh 
reaction conditions, and result in the formation of the aminal products in racemic form.  
This adds an additional step on to the synthesis of the aminal products in order to obtain 
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the enantiomeric pure aminal.  Solid phase methods have also been developed for the 
synthesis of retro-inverso peptide mimics.  Verdini and co-workers have developed solid-
phase methods that can be utilized to carry out oxidative Hofmann-type rearrangement 
resulting in the formation of the retro-inverso peptide mimic in excellent yield.51 
Figure 2.2.  Methods for the Synthesis of Retro-Inverso Peptide Mimics 
2.2.  Development of Bronsted Acid-Catalyzed Amidation of Imines 
 The addition of amides to imines can be traced back to the late 1800’s.  In 1870, 
Roth reported the synthesis of benzylidenediacetamide by heating a neat mixture of 
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acetamide and benzaldehyde (Figure 2.3).52 The resulting aminal was formed in excellent 
yield.  
 
 
 
Figure 2.3.  Condensation of Benzaldehyde with Acetamide 
 Soon after the report by Roth, Bischoff reported a similar reaction between 
urethane and a series of aldehydes.53 Bishoff also reported the condensation of urethane 
with chloral and bromal.  However, in these cases a mixture of products was formed.  
The products were the N,N-aminal product as well as the N,O-aminal product, which 
forms by the simple addition of the amide to the aldehyde. In the 1960’s, Drach and co-
workers reported the addition of amide nucleophiles to imines derived from chloral 
(Figure 2.4).54 
 
 
 
 
Figure 2.4.  Addition of Amides to Chloral-Derived Imines 
 As one can see, the methods reported in the literature generally require harsh 
reaction conditions or the use of imines with two electron-withdrawing substituents.  We 
felt that the development a catalytic method for the addition of amide nucleophiles to 
imines would allow for an expedient route for the synthesis of N,N-aminals.  The 
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resulting aminal products could have potential for incorporation into peptide chains in 
order to develop potentially new retro-inverso peptide mimics. 
 Our approach to the development of a catalytic method for the addition of amides 
to imines was to employ Bronsted acid catalysts for the addition of amides to imines 
containing an acyl-type protecting group on the nitrogen atom of the imine.  We saw this 
reaction to be somewhat analogous to the catalytic methods for the Michael addition of 
amides to enals and enones that had been previously reported in the literature (Figure 
2.5).55 The work of Spencer and co-workers was especially noteworthy in this case.55a 
Spencer and co-workers reported the addition of amides to a variety of Michael acceptors 
could be catalyzed by 10 mol % of the strong Bronsted acid trifluoromethanesulfonimide.  
The reaction showed broad scope in terms of the amide nucleophiles and the Michael 
acceptors. 
 
 
 
 
 
Figure 2.5.  Hypothesis for the Amidation of Imines 
 We began our initial investigations by screening a variety of achiral Bronsted 
acids for the addition of acrylamide to N-Boc protected imines in ether at room 
temperature (Table 2.1).56 The reaction between acrylamide and 1.1 equivalents of imine 
provided the aminal product in 55% yield.  By increasing the imine ratio to two 
equivalents of imine the product was formed in 95% yield.  It was determined after the 
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screening of the Bronsted acid catalyst that trifluoromethanesulfonimide and 
phenylphosphinic acid were excellent catalysts for the additions of amide nucleophiles to 
imines.  Carboxylic acid catalysts resulted in the formation of the product in low to 
moderate yield.  As the pKa of the acid decreased, the reaction was found to be more 
efficient. 
Table 2.1.  Acid Catalyst Screening 
 
 
 
 
 
 
 
 
 
 
 Having determined the optimum catalyst and reaction conditions, we next sought 
to determine the scope of the reaction in terms of the amide nucleophiles (Table 2.2).  It 
was soon discovered that the developed catalytic system could tolerate a variety of amide 
nucleophiles.  The addition of methanesulfonamide and p-toluenesulfonamide to N-Boc 
protected imines provided the respective aminal products in 99% and 91% yield (Entries 
1-2).  The developed reaction was also capable of catalyzing the additions of carbamate 
nucleophiles to N-Boc protected, all resulting in the formation of the aminal products in 
N
H
Boc
O
H2N
Catalyst (10 mol%)
ether, rt
NH
N
H
Boc
O
Catalyst Yield  (%)Entry
1 (S)-camphorsulfonic acid 35
2 tartaric acid 40
3 phenylboronic acid 0
4 L-proline 0
5 nicotinic acid
6 p-nitrobenzoic acid
7 salicylic acid
8 phenylmalonic acid
9 oxalic acid
10 phenylphosphinic acid
11 Tf2NH (0.5 mol%)
trace
trace
17
55
23
97
95
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excellent yields.  The addition of the carbamate nucleophile urethane gave the aminal 
product in 91% yield (Entry 3).  The addition of benzyl carbamate provided the aminal 
product in 81% yield (Entry 4).  The addition of amide nucleophiles was also tolerated by 
the developed catalytic system.  The addition of acrylamide, acetamide, formamide, and 
benzamide all gave the aminal products in excellent yield (Entries 5-8).  The use of 3,5-
dimethoxybenzamide as a nucleophile resulted in the formation of the aminal product in 
84% yield (Entry 9).  However, the employment of 3,5-dinitrobenzamide as the 
nucleophile showed a marked decrease in the yield of the aminal product when compared 
to 3,5-dimethoxybenzamide (Entry 10).  This was probably due to the decreased 
nucleophilicity of the 3,5-dinitrobenzamide due to the presence electron-withdrawing 
nitro substituents on the aromatic ring. 
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Table 2.2.  Variation of the Amide Nucleophiles 
 
 
 
 
 
 
 
 
 
 
 With the reaction showing broad scope in terms of the amide nucleophile, we next 
turned our attention to the scope of the reaction in terms of the imine electrophile (Table 
2.3).  The reactions were screened employing acrylamide as the nucleophile and 
phenylphosphinic acid as the catalyst.  The presence of electron-donating substituents all 
resulted in the formation of the aminal products in greater than 91% yield (Entries 2 and 
4).   Electron-withdrawing groups on the aromatic ring of the imine also resulted in the 
formation of the product in excellent yield.  For example, the use of the 4-bromophenyl 
substituted N-Boc protected imine resulted in the formation of the product in 94% yield 
(Entry 3).  The use of heteroaromatic substituents on the imine electrophile produced the 
N
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O
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0.5 mol% A
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0.5 mol% A
0.5 mol% A
20 min
20 h
20 min
13 h
20 min
19 h
20 min
20 min
99%
91%
97%
81%
87%
91%
97%
91%
Catalyst A = Tf2NH Catalyst B = P
O
H
OH
Ar
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
C(O)CH=CH2
9
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O
R'
R'
R' = OMe
R' = NO2 5 mol% B
5 mol% B 25 h
46 h
84%
49%
Ph
Ph
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HN
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rt
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34 
aminal in excellent yield.  The use of the 2-furyl and 2-thienyl substituted gave the 
respective aminal products in 91% and 99% yield (Entries 4-5). 
Table 2.3.  Variation of Imine Substrate 
 
 
 
 
 
 
 
 
 
2.3. Enantioselective, Bronsted Acid-Catalyzed Amidation of Imines 
 Now knowing that Bronsted acids were capable of catalyzing the addition of a 
variety of amide nucleophiles to imines, we next sought to develop an enantioselective 
method for the additions of amides to imines.  Based upon the work of Terada, we first 
sought to employ the known phosphoric acids derived from BINOL.  The reactions of 
amides and carbamates using BINOL derived phosphoric acid catalysts resulted in the 
formation of the aminal products in excellent yields, but the enantioselectivities for the 
reactions was extremely low.  We soon discovered that the addition of p-
toluenesulfonamide to N-Boc protected imines showed some selectivity (5 % ee) when 
employing BINOL phosphoric acid (Entry 1).  The use of a BINOL phosphoric acid with 
4-(2-naphthyl)-phenyl substituents in the 3 and 3’ position showed an increase in the 
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enantioselectivity of the reaction to 60% ee (Entry 2).  The use of the more sterically 
demanding 4-(1-naphthyl)-phenyl substituted BINOL phosphoric acid also showed an 
increase in the enantioselectivity of the reaction to 71% ee (Entry 3). 
Table 2.4.  Optimization of Enantioselective Addition of Sulfonamides to Imines 
 
 
 
 
 
 
 
 
 At this point, we thought that a new phosphoric acid could prove to be a better 
catalyst for the enantioselective addition of sulfonamides to imines.  We developed a 
phosphoric acid derived from the chiral VAPOL ligand.  Wulff and co-workers at the 
University of Chicago first developed the chiral VAPOL (Vaulted bisPhenthrOL) ligand 
(Figure 2.6).57 VAPOL was thought to be superior to substituted BINOLs due to the fact 
it had a rigid chiral pocket rather than a flexible chiral pocket.  Wulff and co-workers 
have shown that chiral metal complexes of VAPOL could be used for a variety of 
enantioselective transformation, including enantioselective Diels-Alder reactions, 
aziridination of imines, and aza-Diels-Alder reactions.58 The application of the chiral 
phosphoric acid derived from VAPOL to the addition of sulfonamide nucleophiles to the 
Entry R mol% Acid Time
1
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phenyl-substituted N-Boc protected imine resulted in the formation of the aminal product 
in 95% yield and 94% ee (Entry 4).  The reaction employed 5 mol % of the chiral 
phosphoric acid in ether. 
 
Figure 2.6.  Development of VAPOL Phosphoric Acid 
 With the optimized reaction condition in hand, we sought to check the scope of 
the reaction in terms of the sulfonamide nucleophile (Table 2.4).  The addition of 
methanesulfonamide to the phenyl-substituted N-Boc protected imines provided the 
product in 86% yield and 93% ee (Entry 1).  The presence of both electron-donating and 
electron-withdrawing substituents on the sulfonamide nucleophiles was tolerated by the 
reaction conditions.  The addition p-methoxybenzenesulfonamide to the imine provided 
the aminal product in 89% yield and 91% ee (Entry 2).  The addition of p-
chlorobenzenesulfonamide to the imine produced the chiral aminal in 98% yield and 95% 
ee (Entry 4).  The addition of o-toluenesulfonamide to the imine resulted in a decrease in 
both the yield and the enantioselectivity of the product (Entry 3).  This was presumably 
due to the increased steric associated with the nucleophile. 
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Table 2.5.  Variation of Sulfonamide Nucleophiles 
 
 We next investigated the effect of varying the aromatic substituent on the imine 
reactant.  We were happy to discover that the reaction conditions were able to tolerate a 
variety of aromatic substituents on the imine.  It should be noted that either ether or 
toluene could be used as the solvent for the reaction.  In several cases reactions 
performed toluene demonstrated an increase in both the yield and the enantioselectivity 
when compared to the same reaction performed in ether as the solvent.  Electron-donating 
substituents on the aromatic group of the imine resulted in the formation of the product in 
excellent yield and ee.  For example, the addition of p-toluenesulfonamide to the 4-
methoxyphenyl substituted imine resulted in the formation of the product in 92% yield 
and 90% ee (Entry 12).  Electron-withdrawing substituents all provided the aminal 
product in greater than 88% yield and 92% ee (Entries 9-11).  The heterocyclic 2-thienyl 
substituted imine provided the aminal in 94% yield and 88% ee (Entry 13). 
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Table 2.6.  Variation of Imine Substrate 
 
  
  
 
 
 
 
 It should be noted that in order to obtain the product in both high yield and 
enantioselectivity, imines of at least 95% purity must be used in the reaction.  We 
discovered that in order to synthesize the imines of high enough purity, the sulfone 
intermediate that was converted to imine had to be dried in an Abderhalden drying pistol 
for 12 hours.  Dried, powdered molecular sieves were found to be superior to sodium 
sulfate as a drying agent for the conversion of the sulfone to the imine.  Imines that were 
oils were collected using Schlenk filtration methods and concentrated under high 
vacuum.  The solid imines were recrystallized from hexanes prior to use in the reaction.  
It should also be noted that it was required that the catalyst was also dried in an 
Abderhalden drying pistol overnight in order to obtain reproducible yields and 
enantioselectivities. 
2.4. Conclusions 
 We have developed the first catalytic method for the addition of carbamate, 
amide, and sulfonamide nucleophiles to N-Boc protected imines.  Either 
phenylphosphinic acid or trifluoromethanesulfinimide could be used as catalysts for the 
Entry R mol% Acid Time
N
Ar
rt, toluene
HN
Boc
Ar NHR
H2NR
Catalyst
Ar
+
9
10
11
10 mol% PA-5
10 mol% PA-5
10 mol% PA-5
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Ts
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addition of such nucleophiles to the imines.  The reaction was capable of synthesizing the 
N,N-aminal products in excellent yields.  We have also developed the first highly 
enantioselective method for the addition of sulfonamide nucleophiles to N-Boc protected 
imines employing a novel phosphoric acid derived from the VAPOL ligand.  The reaction 
was tolerant of a variety of substituents on both the sulfonamide nucleophile and the 
imine electrophiles. 
 Since our initial publication, our group has extended the described methodology 
to the enantioselective addition of imides to imines.59 The reaction employed VAPOL 
phosphoric acid and was capable of forming the aminal products in excellent yield and 
enantioselectivities.  Our group has also developed Bronsted acid-catalyzed methods for 
the enantioselective addition of phosphorus nucleophiles and alcohols to imines as well 
as employing the VAPOL phosphoric acid for the enantioselective reduction of imino 
esters and desymmetrization of meso-aziridines.60 
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Chapter 3 
Highly Enantioselective Bronsted Acid-Catalyzed Enantioselective Aza-Friedel-
Crafts Reaction 
 The Friedel-Crafts reaction is undoubtedly one of the most important carbon-
carbon bond forming reactions in organic synthesis.61 It is the reaction of electron-rich 
aromatic species with electrophiles.  The reaction is considered to be a green reaction in 
that it is highly atom economical and produces no toxic by-products.  The 
enantioselective addition of indoles to imines allows for the expedient synthesis of chiral 
3-indolylmethanamines, which are important intermediates in the synthesis of many 
biologically active alkaloid natural products such as the Dragmacidins and kopsinine.62 
 
 
 
 
 
Figure 3.1.  Natural Products Containing Chiral 3-Indolylmethanamines 
 3.1. Background 
 The development of the stereoselective Friedel-Crafts reaction date back to 
1985.61 In that year, Sartorri and co-workers reported the enantioselective addition of 
phenols to trichloroacetaldehyde.63 The reaction employed a stoichiometric amount of a 
chiral reagent derived from diethylaluminum chloride and chiral alcohols.  The reaction 
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resulted in the formation of the chiral benzylic alcohols in excellent yields and 
enantioselectivities up to 80%.  Since that time several research groups have developed 
highly enantioselective methods for the addition of indoles to Michael acceptors 
catalyzed by both chiral Lewis acid complexes as well as organocatalyts.64 
 The development of enantioselective methods for the additions of electron-rich 
aromatic compounds to imines has lagged behind the development of the enantioselective 
methodology for the addition of such aromatic compounds to Michael acceptors.  The 
reason for this lag is that the resulting product for the addition of electro-rich aromatics to 
imines and aldehydes was that the products tend to undergo multiple substitutions due to 
the instability of the resulting aminomethyl and hydroxymethyl groups (Figure 3.2). 
Figure 3.2.  Multiple Substitutions of Aminomethyl Intermediates 
 The first catalytic, enantioselective method for the aza-Friedel-Crafts reaction of 
imines and indoles was reported in the literature in 1999.  Johannsen employed a chiral 
Lewis acid catalyst derived from copper hexafluorophosphate and Tol-BINAP to catalyze 
the reaction between indole and imines derived from ethyl glyoxylate and p-
toluenesulfonamide (Table 3.1).65 The reaction employed 10 mol % of the chiral copper 
complex as the catalyst and resulted in the formation of the product in excellent yield and 
enantioselectivity.  A variety of 5-substituted indole derivatives were screened for the 
reaction.  The presence of electron-withdrawing groups on the indole ring resulted in a 
decrease in both the yield and enantioselectivity of the products. 
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Table 3.1.  Johannsen’s Enantioselective aza-Friedel-Crafts Reaction 
 
 It was not until 2006 that a more general method for the enantioselective aza-
Friedel-Crafts reaction of imines with indoles was reported in the literature.  Zhou and 
co-workers reported the enantioselective addition of indoles of N-tosyl protected imines.66 
The reactions employed the use of a catalyst derived from copper(II) triflate and a 
bisoxazoline ligand.  The use of five equivalents of the indole reactant was required in 
order to obtain the product in both excellent yield and ee.  The reaction resulted in the 
formation of the products in excellent yields and enantioselectivities when electron-
withdrawing substituents were attached to the aromatic substituent of the imine.  The 
presence of electron-donating substituents on the aromatic ring of the imine showed a 
general decrease in the yield of the resulting product, but the ee of the product was still 
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greater than 90%.  The use of other protecting groups on the nitrogen atom of the imine 
resulted in a decrease in both the yield and enantioselectivity.  The authors reported that 
the reaction of N-phenyl protected imines resulted in the formation of the desired product 
in 65% yield and 0% ee. 
Table 3.2.  Copper-Catalyzed Enantioselective aza-Friedel-Crafts Reaction 
 
 The first organocatalytic aza-Friedel-Crafts reaction of a heterocycle with an 
imine was reported by Terada and co-workers in 2004.  Terada and co-workers employed 
a chiral phosphoric acid derived from BINOL for the enantioselective addition of a single 
electron-rich furan to N-Boc protected imines.67 Only 2 mol % the chiral phosphoric acid 
catalyst was required in order to form the product in excellent yield and 
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enantioselectivity.  The use of sterically demanding aromatic substituents on the imine 
resulted in the formation of the product in decreased yield, however the enantioselectivity 
of such reactions was not diminished.  The synthetic utility of the reaction was 
demonstrated by the conversion of the resulting products to a γ-butenolide with no loss of 
enantiomeric excess. 
Table 3.3.  Enantioselective aza-Friedel-Crafts Reaction of Furans with Imines 
 
 
  
 
 
 
 
 
 In 2006, Deng and co-workers reported the enantioselective aza-Friedel-Crafts 
reaction of N-benzenesulfonyl protected imines with indole using an organocatalyst.68 
The catalyst that was employed for the reaction was a thiourea derivative of quinine and 
quinidine (Table 3.4).  The reaction required the use of 2 equivalents of the indole 
nucleophile in order to obtain the 3-indolylmethanamine product in excellent yield and 
enantiomeric excess.  The reaction required long reaction times, up to 72 hours, in order 
to obtain the product in high yield when the aromatic substituent of the imine was 
substituted with an electron-withdrawing substituent.  The paper by Deng and co-workers 
was the first report of the enantioselective aza-Friedel-Crafts reaction of aliphatic 
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substituted imines with indoles.  The yield for the reaction of an aliphatic imine with 
indole resulted in the product in a decrease the yield, but the level of enantiomeric excess 
of the product was equal to the enantiomeric excess of the products of the aromatic 
substituted imines.  Deng and co-workers also demonstrated that the tosyl protecting 
group of the imine could be removed and replaced with a Cbz protecting group without 
racemization. 
Table 3.4.  Alkaloid-Catalyzed Enantioselective aza-Friedel-Crafts Reaction 
 
  
 
 
 
 
 
 
 
 
 
 In 2006, Terada and co-workers reported the phosphoric acid catalyzed aza-
Friedel-Crafts reaction of electron-rich enamines with indole derivatives (Table 3.5).69 
The catalyst that was employed for the reaction was BINOL phosphoric acid derivative 
with a 2,4,6-triisopropylphenyl substituents in the 3 and 3’ positions.  The reaction 
resulted in the formation of products in good yields and excellent enantioselectivities for 
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a variety of indole derivatives and enamines.  Terada and co-workers suggested that the 
reaction occurred by first conversion of the enamine starting material to an imine via 
tautomerization.  The chiral phosphoric acid catalysts then activated the imine 
intermediate.  The resulting iminium ion then reacted with the indole derivative resulting 
in the formation of the final product.   
Table 3.5.  Phosphoric Acid-Catalyzed Enantioselective aza-Friedel-Crafts Reaction 
of Indoles with Enamines 
 
 In 2007, You and co-workers reported the enantioselective aza-Friedel-Crafts 
reaction of N-tosyl protected imines with indole derivatives (Table 3.6).70 The reaction 
employed a phosphoric acid catalyst with 1-naphthyl substituents in the 3 and 3’ position 
of the BINOL.  The reaction required the use of five molar equivalents of the indole 
reactant in order to avoid the formation of the multiple addition product.  The presence of 
electron-withdrawing substituents on the aromatic ring of the imine resulted in a slight 
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decrease in both the yield and the enantiomeric excess of the product.  These reactions 
also required longer reaction times than the reactions that employed imines with electron-
donating substituents on the imine, from about 10 minutes for the imines with electron-
donating substituents to 24 hours for the reaction of indole with imines that had electron-
withdrawing substituents. 
Table 3.6.  Phosphoric Acid Catalyzed Enantioselective Aza-Friedel-Crafts Reaction 
3.2.  Enantioselective aza-Friedel-Crafts Reaction of Indole Derivatives with N-
Benzoyl Protected Imines 
 With the success that our group had obtained for the enantioselective addition of 
sulfonamides to N-Boc protected imines, we sought to extend the developed methodology 
to the reaction of nucleophiles to imines. We soon discovered that we were obtaining a 
mixture of products from the reaction.  Characterization of the obtained reaction products 
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indicated that along with the indole adding to the imine by the nitrogen atom, the indole 
was also adding to the imine via the C-3 carbon.  Variation of the reaction conditions 
demonstrated that it was possible to somewhat control which of the two products was 
formed as the major products.  Upon further literature search, it was soon evident that the 
C-3 carbon of indole was the most nucleophilic atom on the indole ring system.71 Based 
upon the experimental and literature evidence that was obtained, we sought to develop a 
phosphoric acid catalyzed method for the enantioselective aza-Friedel-Crafts reaction of 
indole derivatives with imines.   
 Since we had already observed the formation of a mixture of products from the 
reaction of unprotected indole derivatives with N-Boc protected imines catalyzed by 
VAPOL phosphoric acid, we next sought to check the effect of protecting the nitrogen 
atom of the indole ring (Table 3.7).  The first indole derivative that was screened was the 
N-methylindole.  The reaction with the Boc protected imines provided the desired 
product in 94% yield and 15% ee (Entry 2).  The use of N-benzylindole gave the desired 
product in 97% yield and an increase in the ee to 30% (Entry 3).  Solvent screens 
indicated that halogenated solvents provided the products in the enantiomeric excess 
(Entries 4 and 6).  The reason for the higher enantioselectivities and yields that were 
observed for the reaction performed in halogenated solvents was probably due to the 
increased solubility of the starting materials in the halogenated solvents. 
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Table 3.7.  Optimization of Solvent and Indole Protecting Group 
 
 When we changed the protecting group on the nitrogen atom of the imine from a 
Boc protecting group to a benzoyl protecting group, the enantiomeric excess of the 
product increased from 60% to 86% using VAPOL phosphoric acid (Table 3.8).  It 
should be noted that the reactivity of the N-Boc protected imines was much lower than 
the reactivity of the N-benzoyl protected imines.  The reaction of N-Boc protected imines 
at -60 oC resulted in the formation of none of the desired product being formed by the 
reaction (Entry 1).  With the increased enantioselectivity that was observed by replacing 
the Boc protecting group with the benzoyl protecting group, we decided to next screen 
other phosphoric acid catalysts (Entry 2).  Lucky for us, the next phosphoric acid catalyst 
that we screened proved to be the catalyst that resulted in the formation of the desired 
product in the highest yield and enantiomeric excess.  The catalyst was a BINOL 
derivative that had triphenylsilyl substituents in the 3 and 3’ positions.  The catalyst was 
N
H
Boc
PA-5 (10 mol%)
solvent
NH
R1
N
R2
N
R2
Entry R1 R2 Temperature Solvent Yield ee
1 Boc H rt toluene 66 0
2 Boc Me rt toluene 94 15
3 Boc Bn rt toluene 97 30
4 Boc Bn rt (CH2Cl)2 94 40
5 Boc Bn rt ether 65 12
6 Boc Bn rt CH2Cl2 96 45
MeO MeO
7 Boc Piv rt toluene o na
8 Boc TMS rt toluene 31 8
129 130 131
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first reported in the literature by MacMillan and co-workers for the enantioselective 
reduction of imines with Hantzch’s ester.72 The first reaction that was performed with this 
catalyst was at -60 ºC and resulted in the formation of the product in 92% yield and 97% 
ee (Entry 6).  The reason for the increased enantioselectivity could be that the BINOL 
derived catalyst was more bulky than the VAPOL derived catalyst.  It also could be due 
to the flexibility of the chiral pocket of the BINOL derived catalyst.  We went back and 
looked at the effect of varying the reaction temperature with the new catalyst system.  At 
room temperature, the reaction formed the desired product in 99% yield and 80% ee 
(Entry 3).  Lowering the reaction temperature to -30 ºC resulted in the optimal reaction 
condition (Entry 5).  The desired product was formed in 99% yield and 94% ee. 
Table 3.8.  Optimization for the aza-Friedel-Crafts Reaction  
 With the reaction conditions now optimized, we next turned attention to checking 
the scope of the reaction in terms of the imine electrophile (Table 3.9).  We first screened 
SiPh3
SiPh3
O
O
P
O
OH
PA-9
Ph
Ph
O
O
P
O
OH
N
R2
Entry Solvent Yield, %
1 96
R2
solvent, temp
HN
R2
4-OMe
ee %
60
R1
2 89 86
6 92C(O)Ph 97
C(O)Ph
5 mol% Acid
N
R3
N
R3
Boc
H
H
4 Å MS, 16 h
C6H5Cl
CH2Cl2
CH2Cl2
Temp, !C
rt
-60
-60
Acid
PA-5
PA-5
PA-9
R1
3 99 80
4 98 92
5 99C(O)Ph 94
C(O)PhH
H
CH2Cl2
CH2Cl2
rt
-20
-30
PA-9
PA-9
PA-9
H C(O)Ph CH2Cl2
R1
R3
Bn
Bn
Bn
Bn
Bn
Bn
7 70H 30
8 90 30C(O)Ph
C(O)Ph
H
CH2Cl2
CH2Cl2
-30
-30
PA-9
PA-9
H
Me
132 133 134
PA-5
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a series of imines with electron-withdrawing substituents on the para position of the 
aromatic ring of imine.  The reaction of the imine with the strong electron-withdrawing 
nitro substituent in the para position of the imine resulted in the formation of the product 
in 99% yield and 94% ee (Entries 2-5).  The presence of halogen substituents on the para 
position of the aromatic ring of the imine was also well tolerated by the reaction (Entries 
3-5).  All reactions with such substrates resulted in the formation of the desired products 
in greater than 92% yield and greater than 95% ee.  The absolute configuration of the p-
chlorinated product was determined to be (R) by x-ray crystallographic analysis.  This 
was a first for an organocatalytic aza-Friedel-Crafts reaction.   The methodologies 
reported by Deng and You showed a decrease in both the enantiomeric excess and the 
yields of the resulting products when imines containing electron-withdrawing 
substituents were employed in the reaction.  The presence of electron-donating 
substituents on the aromatic ring of the imine also resulted in the formation of the desired 
products in excellent yields and enantioselectivities (Entries 6-9).  The 4-methoxy 
substituted imine resulted in the formation of the desired products in excellent yield and 
enantioselectivities (Entry 7).  Sterically-hindered imines also resulted in the formation of 
the products in excellent yields and enantioselectivities (Entries 9 and 10).  For example, 
the phosphoric acid catalyzed addition of N-benzylindole with the 1-naphthyl substituted 
imine furnished the product in 99% yield and 95% ee (Entry 10). 
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Table 3.9.  Variation of Imine Electrophile 
 
 We next turned our attention to the effect of having substituents on the indole ring 
system (Table 3.10).  We first screened a series of 5-substituted indole substrates.  The 
presence of electron-withdrawing groups on the 5-position of the indole ring gave the 
desired products in excellent yield and enantiomeric excess (Entries 1-2).  The 5-
N
CH2Cl2, -30 !C
NH
Entry Yield % ee %
5 mol% PA-9
N
Bn
N
Bn
4 Å MA, 16 h
R1 R1
1 99 94
2
96 923 97 96
4 92 96
5 97 95
O
Ph
O
Ph
N
C(O)Ph
N
C(O)Ph
MeO
N
C(O)Ph
Cl
N
C(O)Ph
Br
N
C(O)Ph
F
N
C(O)Ph
O2N
N
C(O)Ph
Me
N
C(O)Ph
MeO
N
C(O)PhMeO
N
C(O)Ph
Imine Entry Yield % ee %
6
99 94 7
96 97
8
93 94
9 97 95
10 99 95
Imine
135 136 137a-j
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carboxymethyl and 5-bromo substituted indoles provided the products in slightly lower 
yields and enantioselectivities when compared to the indole with no substituents on the 
ring.  This is probably due to the decreased nucleophilicity of the indole due to the 
lowering of the electron density of the indole ring system.  The presence of the electron-
donating methoxy and methyl substituents on the C-5 carbon of the indole resulted in the 
formation of the desired products in excellent yields and enantioselectivities (Entries 3-
4).  The reaction of the 7-methyl substituted indole gave the desired product in 98% yield 
and 96% ee (Entry 5).  The only indole substrate that resulted in a sharp decrease in the 
enantiomeric excess of the product was 2-methylindole.  The reaction of 2-methylindole 
with the N-benzoyl imine provided the product in 91% yield, but the enantiomeric excess 
of the product was only 64% (Entry 6).  The decrease in the ee was presumably due to 
detrimental steric hindrance. 
 
 
 
 
 
 
 
Figure 3.3.  X-Ray Crystal Determination of Absolute Configuration of 137c 
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Table 3.10. Variation of Indole Substrate 
 
3.3. Conclusions 
   We have developed a highly enantioselective method for addition of N-benzyl 
indole to N-benzoyl protected imines catalyzed by a chiral BINOL phosphoric acid with 
triphenylsilyl substituents on the 3 and 3’ positions of the BINOL ring.  The reaction 
methodology that was developed was capable of synthesizing of a variety of substituted 
3-indolylmethanamines.  The developed methodology had many benefits over the 
N
Ph
CH2Cl2, -30 !C
NH
Ph
5 mol% PA-9
N
Bn
4 Å MS, 16 h
Entry Yield %
1
97
ee %
95
2
94 92
3
89 90
Ph
O O
Ph
R
NH
Ph
N
Bn
O
Ph Me
NH
Ph
N
Bn
O
Ph Br
NH
Ph
N
Bn
O
Ph CO2Me
Product Entry Yield %
4 98
ee %
95
5 98 96
6 91 64
NH
Ph
N
Bn
O
Ph OMe
NH
Ph
N
Bn
O
Ph
NH
Ph
N
Bn
O
Ph
Product
Me
Me
N
Bn
R
138 139 137k-p
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methodology that had been previously reported in the literature.  The developed 
methodology employed the indole reactant as the limiting reagent.  This was beneficial 
due to the fact that the substituted indole starting materials were the more expensive of 
the two starting materials. Another major advantage that the developed methodology had 
over the reported methods was that the react ion was able to tolerate the presence of 
electron-withdrawing substituents on either the indole ring or the aromatic substituent of 
the imine.  The last major benefit that the developed methodology had was the use of the 
N-benzoyl protecting group on the nitrogen of the imine.  In general it is easier to remove 
the benzoyl protecting group than the tosyl protecting group that has bee employed for all 
of the reported methodologies for the enantioselective addition of indole to aromatic 
imines.  The developed methodology does have a drawback when compared to the 
literature methods.  We had to use the N-benzyl protecting group on the nitrogen atom of 
the indole ring in order to obtain the desired product in excellent yield and enantiomeric 
excess while the other methods reported in the literature do not require a protecting group 
on the indole ring.  Since we reported the methodology for the enantioselective aza-
Friedel-Crafts reaction several other research groups have reported chiral phosphoric acid 
catalyzed aza-Friedel-Crafts reactions.73 
 Since our initial report, our group has also developed the first highly 
enantioselective method for the enantioselective addition of pyrrole derivatives to 
imines.74 The reaction employs the same imines and catalyst that were used for the 
enantioselective addition of indoles to imines.  The reaction employed 2 equivalents of 
the imine in order to keep from forming an unwanted side-product.  The reaction 
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produced the desired product in excellent yield and enantiomeric excess for imines with 
both electron-donating and electron-withdrawing substituents.  
Table 3.11.  Enantioselective Addition of Pyrroles to Imines 
 
 
 
 
 
 
 
 
 
 
 
 A project that could be developed out the methodology that was developed was 
the application of chiral phosphoric acid catalysts to the enantioselective addition of 
nucleophiles to racemic 3-indolylmethanamines.  A racemic form of such a process was 
reported by Kobayashi in 2005.75 The reaction should proceed by protonation of the 
nitrogen of the 3-indolylmethanamine.  The loss of the amide functionality would result 
in the formation of a α,β-unsaturated iminium ion.  The phosphate counterion should be 
able to form a chiral ion pair with the resulting iminium ion.  The application of chiral 
phosphate counterions for the development of enantioselective reaction methodology has 
been reported by List and co-workers for the enantioselective reduction of α,β-
R
N Ph
O
N
CH3
CHCl3, -60°C
+
5 mol % PA-9
Entry R Time,h Yield % ee %
1 p-CH3C6H4 25 95 89
2 24 86 90
3 p-CH3OC6H4 20 91 96
4 m-CH3OC6H4 23 97 >99
5 o-CH3OC6H4 24 91 88
6
p-FC6H4 24 96 857
p-ClC6H4 24 90 818
p-BrC6H4 24 92 79
10
1-naph 23 88 82
9
p-CF3C6H4
Ph
26 89 58
HN
R
Ph
O
N
H3C140 141 142
57 
unsaturated enones and enals.28 It should be possible for nucleophiles to add to the chiral 
ion pair with some level of enantiocontrol. 
Figure 3.4.  Acid-Catalyzed Addition of Nucleophiles to Racemic 3-
Indolylmethanamines 
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Chapter 4 
Experimental Procedures 
4.1. Supporting Information for Chapter 2 
4.1.1 General Considerations 
 All reactions were carried out in flame-dried or oven-dried screw-cap test 
tubes and run under a dry argon atmosphere with magnetic stirring.  Ether was purchased 
anhydrous from Fisher and distilled over sodium / benzophenone under a dry argon 
atmosphere.  VAPOL was synthesized according to the literature procedure.57 All imines 
were synthesized according to the literature procedure except Schlenk filtration was 
required for imines of high purity to be isolated.35 Amides, sulfonamides, and BINOL 
were purchased from commercial sources and used without further purification.  
Substituted BINOL phosphoric acids were prepared according to the known literature 
procedure.48 Thin layer chromatography was performed on Merck TLC plates (silica gel 
60 F254). Flash column chromatography was performed with ICN silica gel (230-400 
mesh) or Merck silica gel (230-400 mesh).  IR spectra were recorded on a Perkin Elmer 
Paragon 500 FT-IR instrument for all previously unknown compounds (KBr pellet). 
Enantiomeric excess (ee) was determined using a Hewlett Packard 1050 Series HPLC 
fitted with Daicel Chiralcel OD-H or OJ-H chiral column at 254.4 nm (eluent and flow 
rates shown below). Optical rotations were performed on a Rudolph Research Analytical 
Autopol III polarimeter (λ 589) using a 1-mL cell with a path length of 1-dm.  Melting 
points were determined using a MEL-TEMP 3.0 instrument. 1H NMR and 13C NMR were 
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recorded on a Bruker Avance DRX-500 (500 MHz) instrument with chemical shifts 
reported relative to tetramethylsilane (TMS). The HRMS data were measured on an 
Agilent MSD/TOF mass spectrometer with electrospray ionization. Compounds 
described in the literature were characterized by comparing their 1H NMR, 13C NMR, and 
melting point (mp) to the reported values. 
General procedure for the Brønsted acid-catalyzed amidation of imines. 
The Boc-imine (1 mmol.), amide or sulfonamide (0.5 mmol), and Brønsted acid (0.5-20 
mol %) were weighed into a dry, resealable test tube with septa and stir bar.  The tube 
was evacuated and back-filled with argon and repeated three times. To the mixture was 
added 2 mL of dry ether via syringe and the mixture was stirred vigorously for the 
desired reaction time.  Acetone (2-3 mL) and a scoop of silica gel were added and the 
solvent was removed by rotary evaporation to give a crude solid mixture that was purified 
by column chromatography to provide product 3. 
 
HN
NH
O
O
S
O
O Me
3a  
(±) - tert-butyl methylsulfonamido(phenyl)methylcarbamate (105a) Following the 
general procedure, the product  was obtained  as a white solid in 99% yield. Mp = 161-
163 °C. IR (KBr, cm-1): 3340 (s, NH), 3268 (s, NH), 1686 (s, C=O), 1519 (Ph), 1329 (s, 
SO2), 1153 (s, SO2). 1H NMR (500MHz, CDCl3): δ 1.48 (s, 9H, 3CH3), 3.03 (s, 3H, CH3), 
5.58 (s, 1H, NH), 5.59 (s, 1H, NH) 6.14 (s, 1H, CH), 7.28- 7.48 (m, 5H, Ar-H). 13C NMR 
(125MHz, CDCl3): δ 28.7 (CH3), 42.4 (CH3), 64.3 (CH), 81.4 [C (CH3)3], 126.5, 129.1, 
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129.3, 138.6, 155.2 (C=O). HRMS (ESI) Calcd for C13H20N2NaO4S ([M+Na]+) 323.1042, 
Found 323.1076. 
 
HN
NH
O
O
S
O
O
Me
3b  
(±) - tert-butyl (4-methylphenylsulfonamido)(phenyl)methylcarbamate (105b) 
Following the general procedure, the product  was obtained  as a white solid in 91% 
yield. Mp = 179-180 °C. IR (KBr, cm-1): 3362, 3230, 1684, 1524, 1335, 1163. 1H NMR 
(500MHz, CDCl3): δ 1.37 (s, 9H, 3CH3), 2.44 (s, 3H, CH3), 5.32 (s, br, 1H, NH), 5.76 (s, 
br, 1H, NH), 5.97 (t, J = 8.0 Hz, 1H, CH), 7.28-7.35 (m, 7H, Ar-H), 7.78 (d, J = 8.2 Hz, 
2H, Ar-H). 13C NMR (125MHz, CDCl3): δ 21.93 (CH3), 28.6 (CH3), 64.2 (CH), 80.7 [C 
(CH3)3], 126.4, 127.6, 128.8, 129.0, 130.0, 138.2, 138.9, 143.8, 154.7 (C=O). HRMS 
(ESI) Calcd for C19H24NaN2O4S ([M+Na]+) 399.1354, Found 399.1340. 
 
HN
NH
O
O
OEtO
3c  
 (±) - tert-butyl urethanyl(phenyl)methylcarbamate (105c) Following the general 
procedure, the product  was obtained  as a white solid in 97% yield. Mp = 156-157 °C. IR 
(KBr, cm-1): 3315, 1700, 1654, 1545, 1511. 1H NMR (500MHz, CDCl3): δ 1.25 (t, J =6.8, 
3H, CH3), 1.44 (s, 9H, 3CH3), 4.15 (q, J = 6.8, 2H, CH2), 5.56 (s, br, 2H, 2NH), 6.17 (s, 
1H, CH), 7.31-7.41 (m, 5H, Ar-H). 13C NMR (125Mhz, CDCl3): δ 14.9 (CH2CH3), 28.7 
61 
(CH3), 61.6 (CH), 62.1 (CH2CH3) 81.0 [C (CH3) 3], 126.2, 128.4, 129.0, 139.9, 
155.1(C=O), 156.1(C=O). HRMS (ESI) Calcd for C15H22N2NaO4 ([M+Na]+) 317.1478, 
Found 317.1487. 
 
HN
NH
O
O
OBnO
3d  
(±) - tert-butyl benzylcarbamato(phenyl)methylcarbamate  (105d) Following the 
general procedure, the product  was obtained  as a white solid in 81% yield. Mp = 138-
139 °C. IR (KBr, cm-1): 3323, 1670, 1654, 1543, 1508. 1H NMR (500MHz, CDCl3): 
δ 1.46 (s, 9H, 3CH3), 5.16 (s, 2H, CH2), 5.56 (s, br, 1H, NH), 5.78 (s, br, 1H, NH), 6.22 
(s, 1H, CH), 7.29-7.43 (m, 10H). 13C NMR (125MHz, CDCl3): δ 28.7 (CH3), 62.2 (CH), 
67.4 (OCH2), 80.8 [C(CH3)3], 126.2 (Ar-C), 128.6 (Ar-C), 128.9 (Ar-C), 129.1 (Ar-C), 
136.6 (Ar-C), 139.6, 155.1 (C=O), 155.8 (C=O). HRMS (ESI) Calcd for C20H24NaN2O4  
([M+Na]+) 379.1634, Found 379.1634. 
 
HN
NH
O
O
O
3e  
(±) - tert-butylacrylamido(phenyl)methylcarbamate (105e) Following the general 
procedure, the product  was obtained  as a white solid in 97% yield. Mp = 162-163 °C.  
IR (KBr, cm-1): 3421, 3327, 1690, 1657, 1628, 1548. 1H NMR (500 MHz, CDCl3): δ 1.44 
(s, 9H, 3CH3), 5.70 (d, J = 10.6, 1H, CH), 5.72 (s, br, 1H, NH), 6.15 (dd, J = 10.6, J = 
17.0, 1H, CH), 6.32 (d, J = 17.0, 1H, CH), 6.35 (s, 1H, CH), 6.87 (s, br, NH), 7.28-7.47 
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(m, 5H, Ar-H). 13C NMR (125MHz, CDCl3): δ 28.7 (CH3), 60.7 (CH), 80.9 [C(CH3)3], 
126.2 (Ar-C), 127.9 (CH=CH2), 128.4 (Ar-C), 129.1 (Ar-C), 131.5 (CH=CH2), 139.4 (Ar-
C), 155.4 (C=O), 165.5 (C=O). HRMS (ESI) Calcd for C15H20NaN2O3 ([M+Na]+) 
299.1372, Found 299.1371.  
 
HN
NH
O
O
3f
HO
 
(±) - tert-butyl formamido(phenyl)methylcarbamate (105f) Following the general 
procedure, the product  was obtained  as a white solid in 87% yield. Mp = 144-145°C. IR 
(KBr, cm-1): 3319, 1691, 1543, 1508. 1H NMR (500MHz, CDCl3): δ 1.44 (s, 9H, 3CH3), 
5.42 (s, NH) and 5.79 rotamer, 6.20 (s, NH) and 6.40 rotamer, 6.78 (s, NH) and 7.02 
rotamer, 7.26-7.55 (m, 5H, Ar-H), 8.28 (s, CHO) and 8.40 rotamer. 13C NMR (125MHz, 
CDCl3): δ 28.7, 59.4, 81.0, 126.2, 128.7, 129.1, 129.4, 129.6, 137.9, 138.9, 155.3, 160.9, 
165.1. HRMS (ESI) Calcd for C13H18N2NaO3 ([M+Na]+) 273.1215, Found 273.1227. 
 
HN
NH
O
O
O
3g  
(±) - tert-butyl acetamido(phenyl)methylcarbamate (105g) Following the general 
procedure, the product  was obtained  as a white solid in 91% yield. Mp = 161-163 °C. IR 
(KBr, cm-1): 3327 (s, NH), 1699 (s, C=O), 1653 (s, C=O), 1552, 1509, 1368 (m, CH3). 1H 
NMR (500MHz, CDCl3): δ 1.45 (s, 9H, 3CH3), 2.02 (s, 3H, CH3), 5.93 (s, br, NH), 6.31 
(s, br, NH), 7.10 (s, 1H, CH), 7.29-7.36 (m, 5H, Ar-H). 13C NMR (125MHz, CDCl3): 
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δ 23.6 (CH3), 28.7 (CH3), 60.4 (CH), 80.7 [C (CH3)3], 126.2, 128.3, 129.6, 139.7, 155.5 
(C=O), 170.4 (C=O). HRMS (ESI) Calcd for C14H20NaN2O3 ([M+Na]+) 287.1372, Found 
287.1369. 
 
HN
NH
O
O
O
3h  
(±) - tert-butyl benzamido(phenyl)methylcarbamate (105h) Following the general 
procedure, the product  was obtained  as a white solid in 91% yield. Mp = 154-156 °C. IR 
(KBr, cm-1): 3313, 1689, 1638, 1542, 1509. 1H NMR (500MHz, CDCl3): δ 1.43 (s, 9H, 
3CH3), 6.24 (s, br, 1H, NH), 6.51 (s, 1H, CH), 7.23-7.49 (m, 8H, Ar-H), 7.81  (d, J = 7.5 
Hz, 2H, Ar-H), 7.95 (s, br, 1H, NH). 13C NMR (125MHz, CDCl3): δ 28.7 (CH3), 61.0 
(CH), 80.9 [C(CH3)3], 126.3 (Ar-C), 127.7 (Ar-C), 128.3 (Ar-C), 129.0 (Ar-C), 129.6 
(obscured Ar-C), 132.2 (Ar-C), 134.3 (Ar-C), 139.8 (Ar-C), 155.7 (C=O), 169.9 (C=O). 
HRMS (ESI) Calcd for C19H22NaN2O3 ([M+Na]+) 349.1528, Found 349.1572. 
HN
NH
O
O
O
OMe
OMe
3i
 
(±) - tert-butyl (3,5-dimethoxybenzamido)(phenyl)methylcarbamate (105i) Following 
the general procedure, the product  was obtained  as a white solid in 84% yield. Mp = 
64 
186-187 °C. IR (KBr, cm-1): 3323 (m, NH), 1692 (s, C=O), 1637, 1597, 1509, 1159. 1H 
NMR (500MHz, CDCl3): δ 1.44 (s, 9H, 3CH3), 3.81 (s, 6H, CH3), 5.89 (s, br, 1H, NH), 
6.49 (s, br, 1H, NH), 6.59 (t, 1H, J = 2.0 Hz CH), 6.95 (d, J =1.9 Hz, 2H, Ar-H), 7.29-
7.45 (m, 6H, Ar-H). 13C NMR (125MHz, CDCl3): δ 28.8 (CH3), 56.0 (OCH3), 61.2 (CH), 
81.0 [C (CH3)3], 104.6 (Ar-C), 105.5 (Ar-C), 126.3 (Ar-C), 128.5 (Ar-C), 129.1 (Ar-C), 
136.6 (Ar-C), 139.7 (Ar-C), 155.7 (Ar-C), 161.4 (C=O), 167.3 (C=O). HRMS (ESI) 
Calcd for C21H26NaN2O5 ([M+Na]+) 409.1739, Found 407.177. 
 
 
 
HN
NH
O
O
O
NO2
NO23j  
(±) - tert-butyl (3,5-dinitrobenzamido)(phenyl)methylcarbamate (105j) Following the 
general procedure, the product  was obtained  as a white solid in 49% yield. Mp = 206-
207 °C. IR (KBr, cm-1): 3402 (w, NH), 3332 (m, NH), 1687 (s, C=O), 1654 (s, C=O), 
1545, 1496, 1344 (s, NO2). 1H NMR (500MHz, DMSO): δ 1.42 (s, 9H, 3CH3), 6.59 (t, J 
= 7.1 Hz, 1H, CH), 7.32-7.47 (m, 5H, Ar-H), 7.80 (s, 1H, NH), 8.97 (t, 1H, J = 2.0 Hz, 
Ar-H), 9.12 (d, J =2.0 Hz, 2H, Ar-H), 9.87 (d, J = 7.2 Hz, 1H, NH). 13C NMR (125MHz, 
DMSO): δ 28.1 (CH3), 60.4 (CH), 78.5 [C(CH3)3], 121.0, 126.6, 127.6, 127.8, 127.9, 
128.2, 136.6, 139.5, 148.1 (C=O), 161.6 (C=O). HRMS (ESI) Calcd for C19H20NaN4O7 
439.123, Found 439.1271. 
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HN
NH
O
O
O
Me
3k  
 (±) - tert-butyl acrylamido(o-tolyl)methylcarbamate (105k) Following the general 
procedure, the product  was obtained  as a white solid in 98% yield. Mp = 162-164 °C. IR 
(KBr, cm-1): 3301, 1692, 1657, 1171. 1H NMR (500MHz, CDCl3): δ 1.46 (s, 9H, 3CH3), 
2.42 (s, 3H, CH3), 5.36 (s, br, NH), 5.71 (d, J = 10.4 Hz, 1H, CH), 5.88 (s, br, 1H, NH), 
6.13 (q, dd, 1H, J = 10.3 Hz, J = 16.9 Hz, CH), 6.62 (s, 1H, CH), 7.20-7.29 (m, 4H, Ar-
H), 7.42-7.43 (m, 1H, NH). 13C NMR (125MHz, CDCl3): δ 19.5 (CH3), 28.6 (CH3), 58.8 
(CH), 80.9 [C(CH3)3], 125.3, 126.7, 127.9, 128.8, 130.7, 131.4, 136.2, 137.6, 154.9 
(C=O), 164.9 (C=O). HRMS (ESI) Calcd for C16H22NaN2O3 ([M+Na]+) 313.1528, Found 
313.1532. 
 
HN
NH
O
O
OBr
3l  
(±) - tert-butyl acrylamido(4-bromophenyl)methylcarbamate (105l) Following the 
general procedure, the product  was obtained  as a white solid in 94% yield. Mp = 184.5-
185.0 °C. IR (KBr, cm-1): 3321, 1689, 1627, 1546. 1H NMR (500MHz, CDCl3): δ 1.44 (s, 
9H, 3CH3), 5.74 (d, J = 10.4 Hz, 1H), 5.83 (s, br, 1H, NH), 6.15 (q, dd, 1H, J = 10.4 Hz, 
J = 16.6 Hz, CH); 6.28 (s, br, 1H, CH), 6.33 (d, J = 16.6 Hz, 1H, CH), 6.86 (s, br, 1H, 
NH), 7.27 (d, J = 9.3 Hz, 2H, Ar-H), 7.48 (d, J = 8.5 Hz, 2H, Ar-H). 13C NMR (125MHz, 
CDCl3): δ 28.7 (CH3), 60.3 (CH), 80.8 [C(CH3)3], 122.1, 127.6, 128.0, 130.6, 132.2, 
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138.5, 155.1 (C=O), 165.1 (C=O). HRMS (ESI) Calcd for C15H19BrNaN2O3 ([M+Na]+) 
377.0477, Found 377.0482. 
 
HN
NH
O
O
OMeO
3m  
(±) - tert-butyl acrylamido(4-methoxyphenyl)methylcarbamate (105m) Following the 
general procedure, the product  was obtained  as a white solid in 91% yield. Mp = 167-
169 °C. IR (KBr, cm-1): 3320, 1689, 1658, 1511. 1H NMR (500MHz, CDCl3): δ 1.43 (s, 
9H, 3CH3), 3.78 (s, 3H, 3CH3), 5.68 (d, J = 10.2 Hz, 1H, CH), 5.87 (s, br, 1H, NH), 6.12-
6.17 (q, dd, J=16.9, J = 10.2, 1H, CH), 6.34 (d, 2H, J = 16.9, CH, CH), 6.85-6.87 (m, 2H, 
Ar-H), 6.87 (s, br, NH), 7.27-7.30 (m, 2H, Ar-H). 13C NMR (125MHz, CDCl3): δ 28.3 
(CH3), 55.3, 59.9 (CH), 80.3 [C(CH3)3], 114.0, 127.0, 127.4, 130.5, 131.2, 155.0, 159.3 
(C=O), 165.0 (C=O). HRMS (ESI) Calcd for C16H22N2NaO4 ([M+Na]+) 329.1477, Found 
329.1483. 
 
HN
NH
O
O
O
S
3n  
(±) - tert-butyl acrylamido(thiophen-2-yl)methylcarbamate (105n) Following the 
general procedure, the product  was obtained  as a white solid in 91% yield. Mp = 166-
168 °C. IR (KBr, cm-1): 3318, 3268, 1695, 1664, 1167. 1H NMR (500MHz, CDCl3): 
δ 1.45 (s, 9H, 3CH3), 5.74 (d, J = 10.2 Hz, 1H, CH), 5.9 (s, br, 1H, NH), 6.13 (q, dd, J = 
10.2 Hz, J = 16.9 Hz, 1H, CH), 6.35 (d, J = 16.9, 1H, CH), 6.53 (s, br, 1H, CH), 6.95-
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7.26 (m, 3H). 13C NMR (125MHz, CDCl3): δ 28.7 (CH3), 57.8 (CH), 81.2 [C (CH3)3], 
125.1, 125.7, 127.4, 128.3, 130.7, 143.9, 155.2 (C=O), 165.3 (C=O). HRMS (ESI) Calcd 
for C13H18NaN2O3S ([M+Na]+) 305.0936, Found 305.0945.  
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(±) - tert-butyl acrylamido(furan-2-yl)methylcarbamate (105o) Using the general 
procedure, the product  was obtained  as a white solid in 99% yield. Mp = 162-163 °C. IR 
(KBr, cm-1): 3301 (m, NH), 1691 (s, C=O), 1658 (w, C=O), 1560, 1511. 1H NMR 
(500MHz, CDCl3): δ 1.45 (s, 9H, 3CH3), 5.72 (d, J = 10.2 Hz, 1H, CH), 5.8 (s, br, 1H, 
NH), 6.15 (dd, J = 10.2 Hz, J = 16.9 Hz, 1H, CH), 6.34-6.37 (m, 3H), 6.87 (s, br, NH), 
7.28 (s, 1H, CH), 7.37 (s, 1H, CH). 13C NMR (125MHz, CDCl3): δ 28.7 (CH3), 55.7 
(CH), 81.0 [C (CH3)3], 107.4, 111.0, 128.2, 130.7, 142.6, 151.5, 155.1(C=O), 165.3 
(C=O). HRMS (ESI) Calcd for C13H18NaN2O4 ([M+Na]+) 289.1164, Found 289.1172. 
 
General procedure for chiral VAPOL-phosphoric acid-catalyzed amidation of 
imines 
The Boc-imine (2 equiv.), nucleophile (1equiv) and the VAPOL-phosphoric acid (4-
10mol %) were weighed into a dry tube, and under Argon, injected into dry diethyl ether 
or toluene (1-2 mL). The reaction mixture was stirred at ambient temperature until 
maximum solid precipitated. Added acetone and transfer the resulting mixture to big 
glassware, and then added silica gel (about half spoon). The solvent was evaporated and 
the product was isolated by column chromatography as white solid. The ee of the product 
was determined by chiral HPLC analysis. 
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tert-butyl methylsulfonamido(phenyl)methylcarbamate (105a) Following the general 
procedure, the product  was obtained  as a white solid in 86% yield and 93% ee. HPLC 
analysis: Chiralcel OJ-H (hexane/iPrOH = 85/15, 1.0 mL/min), t r-minor 14.1 min, t r-major 
15.9 min. IR (KBr, cm-1): 3340 (s, NH), 3268 (s, NH), 1686 (s, C=O), 1519 (Ph), 1329 (s, 
SO2), 1153 (s, SO2). 1H NMR (500MHz, CDCl3): δ 1.48 (s, 9H, 3CH3), 3.03 (s, 3H, CH3), 
5.58 (s, 1H, NH), 5.59 (s, 1H, NH) 6.14 (s, 1H, CH), 7.28- 7.48 (m, 5H, Ar-H). 13C NMR 
(125MHz, CDCl3): δ 28.7 (CH3), 42.4 (CH3), 64.3 (CH), 81.4 [C (CH3)3], 126.5, 129.1, 
129.3, 138.6, 155.2 (C=O). HRMS (ESI) Calcd for C13H20N2NaO4S ([M+Na]+) 323.1042, 
Found 323.1076. 
 
(-) - tert-butyl (4-methylphenylsulfonamido)(phenyl)methylcarbamate (105b) 
Following the general procedure, the product  was obtained  as a white solid in 95% yield 
and 94% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 mL/min), t r-
major 10.6 min, t r-minor 12.1 min. [a]20D =  -10.4° (c = 0.23, CHCl3). IR (KBr, cm-1): 3362, 
3230, 1684, 1524, 1335, 1163. 1H NMR (500MHz, CDCl3): δ 1.37 (s, 9H, 3CH3), 2.44 (s, 
3H, CH3), 5.32 (s, br, 1H, NH), 5.76 (s, br, 1H, NH), 5.97 (t, J = 8.0 Hz, 1H, CH), 7.28-
7.35 (m, 7H, Ar-H), 7.78 (d, J = 8.2 Hz, 2H, Ar-H). 13C NMR (125MHz, CDCl3): δ 21.93 
(CH3), 28.6 (CH3), 64.2 (CH), 80.7 [C (CH3)3], 126.4, 127.6, 128.8, 129.0, 130.0, 138.2, 
138.9, 143.8, 154.7 (C=O). HRMS (ESI) Calcd for C19H24NaN2O4S ([M+Na]+) 399.1354, 
Found 399.1340. 
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(+) - tert-butyl (4-methoxyphenylsulfonamido)(phenyl)methylcarbamate (105p) 
Following the general procedure, the product  was obtained  as a white solid in 89% yield 
and 91% ee. HPLC analysis: Chiralcel OJ-H (hexane/iPrOH = 90/10, 1.0 mL/min), t r-minor 
23.43 min, t r-major 30.72 min. [a]20D = 1.86° (c =0.4, CHCl3). Mp = 159-160 °C. IR (KBr, 
cm-1): 3302, 1688, 1156. 1H NMR (500MHz, CDCl3): δ 1.37 (s, 9H, 3CH3), 3.87 (s, 3H, 
CH3), 5.28 (s, br, 1H, NH), 5.52 (s, br, 1H, NH), 5.93 (t, J = 7.6 Hz, 1H, CH), 6.94 (d, J= 
8.9Hz, 2H, Ar-H), 7.28-7.32 (m, 5H, Ar-H), 7.79 (d, J = 8.9 Hz, 2H, Ar-H). 13C NMR 
(125MHz, CDCl3): δ 28.4 (CH3), 55.7 (CH3), 64.1 (CH), 80.7 [C (CH3)3], 114.3, 126.2, 
128.7, 128.9, 129.6, 132.3, 138.4, 155.0, 163.1 (C=O). HRMS (ESI) Calcd for 
C19H24NaN2O5S ([M+Na]+) 415.1303, Found 415.1231. 
 
 
 
HN
NH
O
O
S
O
O
Me
3q  
(+) - tert-butyl (2-methylphenylsulfonamido)(phenyl)methylcarbamate (105q) 
Following the general procedure, the product  was obtained  as a white solid in 80% yield 
and 73% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 mL/min, t r-minor 
8.02 min, t r-major 10.38 min. [a]20D = + 7° (c =0.4, CHCl3). Mp = 147-148 °C. IR (KBr, cm-
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1): 3353, 1692, 1161. 1H NMR (500MHz, CDCl3): δ 1.35 (s, 9H, 3CH3), 2.63 (s, 3H, 
CH3), 5.36 (s, br, 1H, NH), 5.83 (s, br, 1H, NH), 5.88 (t, J = 7.7 Hz, 1H, CH), 7.23-7.29 
(m, 7H, Ar-H), 7.45 (t, 1H, J= 9.2 Hz, Ar-H), 7.87 (d, J = 7.8 Hz, 1H, Ar-H). 13C NMR 
(125MHz, CDCl3): δ 20.4 (CH3), 28.3 (CH3), 64.2 (CH), 80.7 [C (CH3)3], 126.1, 126.4, 
128.6, 128.8, 129.6, 132.5, 132.9, 137.1, 138.0, 138.7, 154.4 (C=O). HRMS (ESI) Calcd 
for C19H24NaN2O4S ([M+Na]+) 399.1354, Found 399.1337. 
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(-) - tert-butyl (4-chlorophenylsulfonamido)(phenyl)methylcarbamate (105r) 
Following the general procedure, the product  was obtained  as a white solid in 98% yield 
and 94% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 mL/min, t r-major 
8.79 min, t r-minor11.26 min. [a]20D = -4.56° (c =0.9, CHCl3). Mp = 166-167 °C. IR (thin 
film, cm-1): 3361, 3221, 1679, 1165. 1H NMR (300MHz, CDCl3): δ 1.38 (s, 9H, 3CH3), 
5.31 (s, br, 1H, NH), 5.77 (s, br, 1H, NH), 6.02 (t, J = 7.9 Hz, 1H, CH), 7.32 (m, 5H, Ar-
H), 7.45 (d, 2H, J= 8.6 Hz, Ar-H), 7.78 (d, J = 8.6 Hz, 1H, Ar-H). 13C NMR (125MHz, 
CDCl3): δ 28.2 (CH3), 64.0 (CH), 80.8 [C (CH3)3], 126.0, 128.6, 128.7, 128.8, 129.2, 
137.9, 139.2, 139.3, 154.3 (C=O). HRMS (ESI) Calcd for C19H24NaN2O4S ([M+Na]+) 
397.0991, Found 397.0988. 
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(+) – tert-butyl (4-chlorophenyl)(4-methylphenylsulfonamido)methylcarbamate 
(105s) Following the general procedure, the product  was obtained  as a white solid in 
88% yield and 95% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 
mL/min, t r-majorr 8.48 min, t r-minor 13.30 min. [a]20D = +2.84° (c =1.07, CH2Cl2). Mp = 168-
169°C. IR (thin film, cm-1): 3334, 3266, 1681, 1520, 1444, 1347, 1160. 1H NMR 
(300MHz, CDCl3): δ 1.33 (s, 9H, 3CH3), 2.44 (s, 3H, CH3), 5.36 (s, br, 1H, NH), 5.89 (s, 
br, 2H, NH, CH overlap),  7.27 (d, 2H, Ar-H), 7.72 (t, 1H, J= 9.2 Hz, Ar-H), 7.87 (d, J = 
7.8 Hz, 1H, Ar-H). 13C NMR (125MHz, CDCl3): δ 21.6 (CH3), 28.2 (CH3), 63.6 (CH), 
80.8 [C (CH3)3], 127.2, 127.6, 128.8, 129.7, 134.4, 136.8, 137.7, 143.7, 154.2 (C=O). 
HRMS (ESI) Calcd for C19H24NaN2O4S ([M+H]+) 411.1147, Found 411.1145. 
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(-) - tert-butyl (4-bromophenyl)(4-methylphenyl)methylcarbamate (105t) Following 
the general procedure, the product  was obtained  as a white solid in 96% yield and 91% 
ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 mL/min, t r-major 8.65 
min, t r-minor 16.74 min. [a]20D = -3.45° (c =1.1, CHCl3). Mp = 172-173 °C. IR (KBr, cm-1): 
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3339, 3262, 1685, 1519, 1319, 1158. 1H NMR (500MHz, CDCl3): δ 1.37 (s, 9H, 3CH3), 
2.46 (s, 3H, CH3), 5.35 (s, br, 1H, NH), 5.82 (s, br, 1H, NH), 5.87 (t, 1H, J = 7.7 Hz, 
CH), 7.20 (d, 2H, J = 8.4 Hz, Ar-H), 7.30 (d, 2H, J= 8.3 Hz, Ar-H), 7.43 (d, 2H, J = 8.5 
Hz, Ar-H), 7.73(d, 2H, J = 8.2 Hz, Ar-H). 13C NMR (125MHz, CDCl3): δ 21.6 (CH3), 
28.2 (CH3), 63.6 (CH), 80.8 [C (CH3)3], 122.6, 127.2, 127.9, 129.8, 131.8, 137.3, 137.7, 
143.7, 154.3 (C=O). HRMS (ESI) Calcd for C19H24NaN2O4S ([M+H]+) 455.0644, Found 
455.0640. 
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(-) - tert-butyl (2-methylphenylsulfonamido)(4-
(trifluoromethyphenyl)methylcarbamate (105u) Following the general procedure, the 
product  was obtained  as a white solid in 99% yield and 99% ee. HPLC analysis: 
Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 mL/min, t r-major 7.00 min, t r-minor 11.50 min. 
[a]20D = -4.29° (c =1.0, DMSO). Mp = 185-186 °C. IR (KBr, cm-1): 3441, 1654, 1317, 
1163. 1H NMR (500MHz, CDCl3): δ 1.36 (s, 9H, 3CH3), 2.43 (s, 3H, CH3), 5.41 (s, br, 
1H, NH), 5.84 (s, br, 1H, NH), 5.92 (t, 1H, J = 8.2 Hz, CH), 7.27 (d, 2H, J = 9.43, Ar-H), 
7.44 (d, 1H, J= 8.2 Hz, Ar-H), 7.54 (d, 2H, J = 8.2 Hz, Ar-H), 7.70(d, 2H, J = 8.3). 13C 
NMR (125MHz, DMSO): δ 20.9 (CH3), 28.0 (CH3), 62.6 (CH), 78.5 [C (CH3)3], 125.2, 
126.5, 127.2, 128.2, 128.5, 129.2, 138.8, 142.3, 144.2, 154.4 (C=O). HRMS (ESI) Calcd 
for C19H24NaN2O4S ([M+H]+) 445.1410, Found 445.1409. 
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(-) - tert-butyl (4-methoxyphenyl)(4-methylphenylsulfonamido)methylcarbamate 
(105v) Following the general procedure, the product  was obtained  as a white solid in 
92% yield and 90% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 
mL/min, t r-major 14.116 min, t r-minor 26.924 min. [a]20D = - 3.36° (c =1.0, CHCl3). Mp = 151-
152°C. IR (KBr, cm-1): 3337, 3283, 1684, 1512, 1367, 1306, 1161. 1H NMR (500MHz, 
CDCl3): δ 1.38 (s, 9H, 3CH3), 2.44 (s, 3H, CH3), 3.80(s, 3H, OCH3), 5.23 (s, br, 1H, 
NH), 5.56 (s, br, 1H, NH), 5.90 (t, J = 7.7 Hz, 1H, CH), 6.82(d, J = 8.8 Hz, 2H, Ar-H), 
7.22(d, J = 8.8 Hz, 2H, Ar-H), 7.29(d, J =  7.7 Hz, 2H, Ar-H), 7.75(d, J = 8.3 Hz, 2H, 
AR-H). 13C NMR (75MHz, CDCl3): δ 21.5 (CH3), 28.2 (CH3), 55.3 (OCH), 80.7 [C 
(CH3)3], 114.0, 127.3, 127.3, 129.6, 137.7, 143.45, 154.2, 159.64 (C=O). HRMS (ESI) 
Calcd for C19H24NaN2O4S ([M+H]+) 407.1643, Found 407.1641. 
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(+) - tert-butyl (4-methylphenylsulfonamido)(thiophen-2-yl)methylcarbamate (105w) 
Following the general procedure, the product  was obtained  as a white solid in 94% yield 
and 87% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 mL/min, t r-major 
8.86 min, t r-minor 12.15 min. [a]20D = + 7° (c =0.4, CHCl3). Mp = 172-173 °C. IR (KBr, cm-
1): 3351, 3214, 1676, 1332, 1161. 1H NMR (500MHz, CDCl3): δ 1.38 (s, 9H, 3CH3), 2.45 
74 
(s, 3H, CH3), 5.40 (s, br, 1H, NH), 5.95 (s, br, 1H, NH), 6.14 (t, J = 8.17 Hz, 1H, CH), 
6.94 (t, 1H, J = ,5.4, Ar-H), 6.97 (s, br, 1H, Ar-H), 7.24 (d, 1H, J= 4.9 Hz, Ar-H), 7.31 
(d, 2H,  J = 8.1 Hz,  Ar-H). 13C NMR (125MHz, CDCl3): d 21.6 (CH3), 28.2 (CH3), 61.2 
(CH), 80.7 [C (CH3)3], 125.2, 125.9, 127.2, 127.2, 129.7, 137.8, 143.0, 143.6, 154.0 
(C=O). HRMS (ESI) Calcd for C19H24NaN2O4S ([M-H]-) 381.0942, Found 381.0998. 
 
 
4.2. Supporting Information for Chapter 3 
 
4.2.1 General Considerations 
                  All reactions were carried out in flame-dried screw-cap test tubes fitted 
with a septum and performed under a dry argon atmosphere with magnetic stirring.  All 
solvents were purified by passing the degassed solvent through a column of activated 
alumina prior to use in reactions.  The indole substrates used for the reactions were 
prepared by following literature procedures.64d Chiral phosphoric acid catalyst PA-557 and 
PA-672 were prepared by literature procedures.  Thin layer chromatography was 
performed on Merck TLC plates (silica gel 60 F254). Flash column chromatography was 
performed with an Isco-Teledyne Companion 4X chromatography system. Enantiomeric 
excess (ee) was determined using a Varian Prostar HPLC system with a Prostar 210 
binary pump and Prostar 335 diode-array detector with Daicel Chiralcel OD-H or AD-H 
chiral column (eluent and flow rates shown below). 1H NMR and 13C NMR were 
recorded on a Varian Inova 400 or a Varian Inova 500 instrument with chemical shifts 
reported relative to residual chloroform. The HRMS data were measured on an Agilent 
1100 series MSD/TOF mass spectrometer with electrospray ionization. Compounds 
described in the literature were characterized by comparing their 1H NMR, 13C NMR, and 
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melting point (mp) to the reported values. 
4.2.2. Experimental Procedures 
1)  General procedure for the preparation of N-acyl imines. 
Following a modified procedure of Terada77, N-Benzoyl-1-methoxy-1-aryl methylamine 
(10 mmol), oven-dried K2CO3, and oven-dried Na2SO4 were weighed into an oven-dried 
200-mL RB flask.  Toluene (100 mL) was added to the flask and the resulting suspension 
was heated to reflux for 12 h.  The suspension was cooled to ambient temperature, 
filtered through celite, and concentrated in vacuo.  The residue was triturated with hexane 
until the residue was a uniform solid.  The resulting imines were used in reactions 
without further purification. 
2)  General procedure for the preparation of racemic 3-indolylmethanamines 
The imine (0.50 mmol), N-benzyl indole (0.25 mmol), and phenylphosphinic acid (4 mg, 
0.025 mmol) were weighed into a test tube.  The air was removed under vacuum and 
replaced with argon.  CH2Cl2 (2 mL) was added to the test-tube via syringe, and the 
reaction was stirred at room temperature for 1 hour.  The reaction was diluted with 
CH2Cl2, concentrated on silica gel, and purified by flash column chromatography.  
3)  General procedure for the enantioselective aza Friedel-Crafts reaction 
To a flame-dried test tube containing 200mg of activated, powdered 4 Å molecular sieves 
and a magnetic stir bar was added imine (0.50 mmol) and acid catalyst (11.0mg, 0.013 
mmol).  The air was removed with vacuum and replaced with argon, and 1 mL of CH2Cl2 
was added to the test tube via syringe.  The resulting solution was placed into a -30 oC 
bath and allowed to stir for 5 minutes.  N-benzyl indole (0.25 mmol) was weighed into a 
separate flame-dried vial.  The air was removed and replaced with argon, and 1 mL of 
CH2Cl2 was added to the vial via syringe.  The resulting indole solution was transferred to 
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the test tube containing the imine and catalyst by dropwise addition over a period of 
approximately 1 minute.  The resulting solution was allowed to stir for 16 h at -30oC, at 
which point the reaction mixture was diluted with CH2Cl2, concentrated on silica gel and 
purified by flash column chromatography. 
 
 
 
 
 
 
(+)-N-((1-benzyl-1H-indol-3-yl)(phenyl)methyl)benzamide (137a) Following the 
general procedure, the product  was obtained  as a white solid in 99% yield and 94% ee. 
HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 85/15, 1.0 mL/min), t r-major 15.80 min, 
t r-minor 20.16 min. [α]25D = 66.1º (c = 1.0, CHCl3). Mp = 203.3-204.9 ºC. IR(solid, cm-1): 
3317, 3234, 3029, 1629, 1521, 1490, 1350, 1336, 798, 699.  1H NMR (500MHz, CDCl3): 
δ 5.28 (s, 2H), 6.79 (m, 3H), 7.13 (m, 3H), 7.23 (t, J = 8.3 Hz, 1H), 7.30 (m, 5H,), 7.40 (t, 
J = 7.8 Hz, 2H), 7.45 (t, J =7.8 Hz, 2H), 7.51 (m, 3H), 7.60 (d, J = 7.8 Hz, 1H) 7.84 (d, J 
=7.3 Hz, 2H). 13C NMR (125MHz, CDCl3): δ 50.4, 51.2, 110.4, 116.7, 119.9, 120.1, 
122.7, 126.9, 127.0, 127.3, 127.3, 127.6, 127.9, 128.1, 128.8, 128.9, 129.1, 131.8, 134.7, 
137.4, 137.5, 141.6, 166.7. HRMS (ESI) Calcd for C29H24N2NaO ([M+Na]+) 439.1781, 
Found 439.1785. 
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(+)-N-((1-benzyl-1H-indol-3-yl)(4-nitrophenyl)methyl)benzamide (137b) Following 
the general procedure, the product  was obtained  as a white solid in 99% yield and 94% 
ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 32.96 
min, t r-minor 44.56 min. [α]25D = 49.1º (c = 1.0, CHCl3). Mp = 176.0-177.7 ºC. IR(solid, 
cm-1): 3316, 3062, 2978, 1626, 1508, 1486, 1335, 1177, 1026, 739, 691. 1H NMR 
(500MHz, CDCl3): δ 5.28 (d, J= 3.4 Hz, 2H), 6.77 (m, 2H), 7.14 (m, 3H), 7.28-735 (m, 
4H), 7.43-7.60 (m, 6H), 7.65 (d, J = 8.7 Hz, 2H), 7.83 (d, J = 7.3 Hz, 2H), 8.23 (d, J = 
8.7 Hz, 2H). 13C NMR (125MHz, CDCl3): δ  110.7, 115.1, 119.3, 120.6, 123.1, 124.3, 
126.5, 127.9, 128.0, 128.2, 129.0, 129.1, 129.1, 132.2, 133.9, 137.0, 147.5, 149.2, 167.0. 
HRMS (ESI) Calcd for C29H23NaN3O3 ([M+Na]+) 484.1632, Found 484.1630. 
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(+)-(R)-N-((1-benzyl-1H-indol-3-yl)(4-chlorophenyl)methyl)benzamide (137c) 
Following the general procedure, the product  was obtained  as a white solid in 97% yield 
and 96% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 85/15, 1.0 mL/min), t r-
major 17.28 min, t r-minor 23.29 min. [α]25D = 80.4º (c = 1.0, CHCl3). Mp = 236.7-237.9 ºC. 
IR(solid, cm-1): 3305, 1629, 1515,1482, 1343, 1177, 1085, 824, 732, 718. 1H NMR 
(500MHz, CDCl3): δ 5.26 (s, 2H), 6.68-6.77 (m, 3H), 7.11-7.56 (m, 16H), 7.81 (d, J = 7.3 
Hz, 2H).  13C NMR (125MHz, CDCl3): δ 50.4, 50.7, 110.4, 116.1, 119.6, 120.3, 122.8, 
126.7, 126.9, 127.3, 127.9, 128.0, 128.6, 128.9, 128.9, 129.0, 131.9, 133.2, 134.4, 137.3, 
137.4, 140.1, 166.7. HRMS (ESI) Calcd for C29H23ClN2NaO ([M+Na]+) 473.1391, Found 
473.1390. 
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(+)-N-((1-benzyl-1H-indol-3-yl)(4-bromophenyl)methyl)benzamide (137d) Following 
the general procedure, the product  was obtained  as a white solid in 92% yield and 96% 
ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 13.69 
min, t r-minor 17.65 min. [α]25D = 74.3º (c = 1.1, CHCl3). Mp = 220.3-221.3 ºC. IR(solid, 
cm-1): 3291, 2966, 1629, 5024, 1485, 1468, 1089, 1073, 1011, 735, 713. 1H NMR 
(500MHz, CDCl3): δ 5.24 (s, 2H), 6.65 (d, J = 7.3 Hz, 1H), 6.73 (m, 2H), 7.08 (m, 2H), 
7.14-7.34 (m, 8H), 7.39-7.53 (m, 6H), 7.78 (d, J = 7.3 Hz, 2H).13C NMR (125MHz, 
CDCl3): δ 50.5, 50.8, 110.5, 116.0, 119.7, 120.3, 121.4, 122.8, 126.8, 127.0, 127.3, 128.0, 
128.0, 128.9, 129.0, 129.1, 131.9, 132.0, 134.4, 137.3, 137.4, 140.7, 166.8. HRMS (ESI) 
Calcd for C29H23BrN2NaO3 ([M+Na]+) 517.0886, Found 517.0881. 
 
 
 
 
 
(+)-N-((1-benzyl-1H-indol-3-yl)(4-fluorophenyl)methyl)benzamide (137e) Following 
the general procedure, the product  was obtained  as a white solid in 97% yield and 95% 
ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 11.60 
min, t r-minor 15.49 min. [α]25D = 75.1º (c = 1.0, CHCl3). Mp = 194.5-195.3 ºC. IR(solid, 
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cm-1): 3344, 3064, 2926, 1628, 1511, 1487, 1248, 1179, 1029, 738, 692. 1H NMR 
(500MHz, CDCl3): δ 5.28 (s, 2H), 6.78 (m, 3H), 7.07 (t, J= 8.3 Hz, 2H), 7.12 (m, 3H), 
7.23 (t, J = 7.3 Hz, 1H), 7.31 (m, 4H), 7.45 (m, 4H), 7.54 (m, 2H), 7.83 (d, J = 7.3 Hz, 
2H). 13C NMR (125MHz, CDCl3): δ 50.5, 50.6, 110.5, 115.6 (d, J = 21.6 Hz), 116.4, 
119.8, 120.3, 122.8, 126.9, 127.0, 127.3, 127.9, 128.0 (d, J = 8.6 Hz), 128.8, 128.9, 
129.1, 131.9, 134.5, 137.4 (d, J = 2.9 Hz), 137.5, 162.0 (d, J = 245.5 Hz), 166.8. HRMS 
(ESI) Calcd for C29H23FN2NaO ([M+Na]+) 457.1687, Found 457.1683. 
 
 
 
 
 
 
(+)-N-((1-benzyl-1H-indol-3-yl)(p-tolyl)methyl)benzamide (137f) Following the 
general procedure, the product  was obtained  as a white solid in 96% yield and 97% ee. 
HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 10.95 min, t 
r-minor 13.55 min. [α]25D = 66.7º (c = 1.1, CHCl3). Mp = 212.4-215.5 ºC. IR(solid, cm-
1):3335, 3063, 1622, 1519, 1486, 1335, 1173, 821, 747, 692. 1H NMR (500MHz, CDCl3): 
δ 2.38 (s, 3H), 5.28 (s, 2H), 6.73 (d, J = 7.8, 1H), 6.77 (d, J =7.8, 1H), 6.82 (s, 1H), 7.11 
(m, 2H), 7.21 (m, 3H),  7.26 (m, 3H), 7.38 (d, J = 8.3 Hz, 3H), 7.44 (t, J = 7.8 Hz, 3H), 
7.51 (t, J = 7.3 Hz, 1H), 7.59 (d, J = 7.8 Hz, 1H), 7.83 (d, J = 6.8 Hz, 2H).13C NMR 
(125Mhz, CDCl3): δ  21.4, 50.4, 50.9, 110.3, 116.8, 119.9, 120.1, 122.6, 126.9, 127. , 
127.2, 127.3, 127.9, 128.0, 128.8, 129.0, 129.4, 131.8, 134.8, 137.2, 137.4, 137.5, 138.6, 
166.7.  HRMS (ESI) Calcd for C30H26N2NaO ([M+Na]+) 453.1937, Found 453.1938. 
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(+)-N-((1-benzyl-1H-indol-3-yl)(4-methoxyphenyl)methyl)benzamide (137g) 
Following the general procedure, the product  was obtained  as a white solid in 93% yield 
and 94% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-
major 18.00 min, t r-minor 23.45 min. [α]25D = 72.1º (c = 1.0, CHCl3). Mp = 232.6-233.1 ºC. 
IR(solid, cm-1): 3325, 3064, 1625, 1530, 1513, 1247, 1176, 1027, 750, 732, 693. 1H NMR 
(500MHz, CDCl3): δ 3.83 (s, 3H), 5.28 (s, 2H), 6.72 (d, J = 7.8 Hz, 1H), 6.76 (d, J = 6.8 
Hz, 1H),  6.83 (s, 1H ), 6.92 (d, J = 6.8 Hz, 2H ), 7.11 (m, 3H), 7.22 (t, J = 7.3 Hz, 1H ), 
7.31 (m, 4H), 7.42 (m, 4H), 7.51 (m, 1H), 7.57 (d, J = 7.8 Hz, 1H), 7.83 (d, J = 7.8 Hz, 
2H ). 13C NMR (125MHz, CDCl3): δ  50.1, 50.4, 55.3, 110.1, 113.9, 116.6, 119.8, 122.3, 
126.7, 126.7, 126.8, 127.0, 127.7, 128.2, 128.6, 128.8, 131.5, 133.5, 134.5, 137.2, 142.9, 
158.8, 166.4.  HRMS (ESI) Calcd for C30H26N2KO2 ([M+K]+) 485.1628, Found 485.1628. 
 
 
 
 
 
(+)-N-((1-benzyl-1H-indol-3-yl)(3-methoxyphenyl)methyl)benzamide (105h) white 
solid. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 
14.88 min, t r-minor 23.05 min. [α]25D = 69.1º (c = 1.0, CHCl3). Mp = 194.8-195.2 ºC. 
IR(solid, cm-1): 3366, 3026, 2918, 1629, 1517, 1488, 1466, 1350, 1283, 1240, 1165, 
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1037, 791, 771, 741, 695. 1H NMR (500 MHz, CDCl3): δ 3.81 (s, 3H), 5.27 (s, 2H), 6.78 
(m, 1H), 6.84 (m, 3H), 7.08-7.62 (m, 15H), 7.84 (d, J = 7.8 Hz, 2H). 13C NMR (125MHz, 
CDCl3): δ 50.4, 51.1, 55.5, 110.4, 112.8, 113.3, 116.6, 119.7, 119.9, 120.2, 122.7, 127.0, 
127.1, 127.4, 128.0, 128.1, 128.9, 129.1, 129.8, 131.8, 134.7, 137.4, 137.5, 143.3, 160.0, 
166.8. HRMS (ESI) Calcd for C30H26N2NaO2 ([M+Na]+) 469.1887, Found 469.1881.  
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(+)-N-((1-benzyl-1H-indol-3-yl)(2-methoxyphenyl)methyl)benzamide (137i) 
Following the general procedure, the product  was obtained  as a white solid in 97% yield 
and 95% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-
major 12.09 min, t r-minor 15.20 min. [α]25D = 90.9º (c = 1.0, CHCl3). Mp = 195.5-196.4 ºC. 
IR(solid, cm-1): 3338, 3062, 2975, 1633, 1515, 1490, 1350, 1243, 1177, 1026, 732, 693. 
1H NMR (500MHz, CDCl3): δ 3.82 (s, 3H), 5.24 (d, J = 5.3 Hz, 2H), 6.70 (s, 1H), 6.99 
(m, 3H), 7.10 (m, 3H), 7.19 (t, J = 6.8 Hz, 1H),  7.24-7.32 (m, 6H), 7.43-7.50 (m, 4H), 
7.72 (d, J = 7.8 Hz, 1H), 7.83 (m, 2H). 13C NMR (125MHz, CDCl3): δ 48.3, 50.2, 55.8, 
110.1, 111.6, 116.4, 119.9, 120.1, 121.2, 122.3, 126.9, 127., 127.3, 127.3, 127.8, 128.8, 
128.9, 128.9, 129.0, 129.6, 131.6, 135.1, 137.3, 137.8, 157.7, 166.3. HRMS (ESI) Calcd 
for C30H26N2NaO2 ([M+Na]+) 469.1887, Found 469.1882. 
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(+)-N-((1-benzyl-1H-indol-3-yl)(naphthalen-1-yl)methyl)benzamide (137j) Following 
the general procedure, the product  was obtained  as a white solid in 99% yield and 95% 
ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 11.41 
min, t r-minor 16.09 min. [α]25D = 113.9º (c = 1.0, CHCl3). Mp = 227.8-228.9 ºC. IR(solid, 
cm-1): 3272, 2980, 1627, 1577, 1538, 1381, 1162, 953, 745, 696. 1H NMR (500MHz, 
DMSO): δ 5.18 (s, 1H), 6.50 (s, 1H), 6.84 (d, J = 7.5, 1H), 7.01 (d, J = 6.0 Hz, 2H ), 7.13 
(t, J = 7.1 Hz, 1H), 7.26 (m, 6H), 7.45 (m, 7H), 7.65 (m, 2H), 7.85 (d, J = 7.3 Hz, 2H), 
7.89 ( d, J = 8.1 Hz, 2H), 8.11 (d, J = 8.2 Hz, 1H). 13C NMR (125MHz, DMSO): δ 48.2, 
50.3, 110.4, 116.4, 119.9, 120.2, 122.7, 124.0, 124.5, 125.6, 126.0, 126.5, 126.8, 127.2, 
127.4, 127.9, 128.5, 128.6, 128.9, 128.9, 129.0, 131.5, 131.9, 134.3, 134.6, 132.7, 137.4, 
137.5, 166.6. HRMS (ESI) Calcd for C33H26N2NaO 489.1937,  Found 489.1931. 
 
 
 
 
 
 
(+)-N-((1-benzyl-5-methyl-1H-indol-3-yl)(phenyl)methyl)benzamide (137k) 
Following the general procedure, the product  was obtained  as a white solid in 97% yield 
and 95% ee. HPLC analysis: Chiralcel AD-H (hexane/iPrOH = 85/15, 1.0 mL/min), t r-
minor 13.32 min, t r-major 14.44 min. [α]25D = 60.1º (c = 1.0, CHCl3). Mp = 187.0-188.1 ºC. 
IR(solid, cm-1): 3338, 3029, 2982, 1633, 1515, 1251, 1170, 1026, 795, 740, 692. 1H NMR 
(500MHz, CDCl3): δ 2.41 (s, 3H), 5.22 (s, 2H), 6.73 (d, J = 4.3 Hz, 2H), 6.79 (d, J = 7.8 
Hz, 1H), 7.03 (d, J = 8.3 Hz, 1H), 7.09 (d, J = 7.3 Hz, 2H), 7.16 (d, J = 8.3 Hz, 1H), 7.26-
7.32 (m, 4H), 7.38 (m, 3H), 7.43 (m, 2H), 7.50 (m, 3H), 7.83 (d, J = 6.3 Hz, 2H).13C 
NMR (125MHz, CDCl3): δ 21.4, 50.1, 50.8, 109.8, 115.8, 119.1, 124.0, 126.6, 126.9, 
N
HN
O
Ph
Ph
83 
127.0, 127.0, 127.2, 127.6, 127.9, 128.5, 128.5, 128.7, 129.2, 131.5, 134.4, 135.5, 137.3, 
141.4, 166.5. HRMS (ESI) Calcd for C30H26N2NaO ([M+Na]+) 453.1937, Found 
453.1937. 
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(+)-N-((1-benzyl-5-bromo-1H-indol-3-yl)(phenyl)methyl)benzamide (137l) Following 
the general procedure, the product  was obtained  as a white solid in 94% yield and 92% 
ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 85/15, 1.0 mL/min), t r-
major18.68min, t r-minor 22.19 min. [α]25D = 35.5º (c = 1.0, CHCl3). Mp = 184.8-186.2 ºC. 
IR(solid, cm-1): 3301, 3059, 2975, 1626, 1523, 1486, 1343, 1269, 1207, 1052, 747, 699. 
1H NMR (500MHz, CDCl3): δ 5.24 (s, 2H), 6.72 (d, J = 7.8 Hz, 1H),  6.78 (d, J = 7.8 Hz, 
1H),  6.85 (s,1H),  7.08 (d, J = 6.8 Hz, 2H),  7.14 (d, J = 8.8 Hz, 1H), 7.24-7.34 (m, 4H),  
7.40 (t, J = 6.8 Hz, 2H), 7.46 (m, 5H),  7.53 (m, 1H), 7.67 (d, J = 1.4 Hz, 1H), 7.84 (d, J 
= 6.8 Hz, 2H)13C NMR (125MHz, CDCl3): δ 50.6, 50.9, 110.1, 111.9, 113.5, 116.2, 
122.4, 125.6, 126.8, 127.3, 127.3, 127.8, 128.1, 128.7, 128.9, 129.1, 129.1, 132.0, 134.6, 
136.1, 137.0, 141.2, 166.8. HRMS (ESI) Calcd for C29H23BrN2NaO ([M+Na]+) 517.0886, 
Found 517.0884. 
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(+) - methyl 1-benzyl-3-(phenyl(phenylamido)methyl)-1H-indole-5-carboxylate 
(137m) Following the general procedure, the product  was obtained  as a white solid in 
84 
89% yield and 90% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 
mL/min), t r-major 16.44 min, t r-minor 21.27 min. [α]25D = 26.7º (c = 1.0, CHCl3). Mp = 195.2-
196.3 ºC. IR(solid, cm-1): 3313, 3026, 2919, 1714, 1626, 1519, 1486, 1350, 1302, 1247, 
1181k 1026, 732, 696. 1H NMR (500MHz, CDCl3): δ 3.88 (s, 3H), 5.29 (s, 2H), 6.78-
6.80 (m, 2H), 6.91 (s, 1H), 7.11 (d, J = 6.3 Hz, 2H), 7.29-7.52 (m, 12H), 7.84 (d, J = 7.3, 
2H), 7.92 (d, J = 8.7, 1H), 8.33 (s, 1H).  13C NMR (125MHz, CDCl3): δ 50.6, 51.1, 52.1, 
110.1, 118.1, 122.3, 122.7, 124.1, 126.5, 127.0, 127.3, 127.3, 127.8, 128.2, 128.9, 128.9, 
129.2, 129.3, 131.9, 134.6, 136.8, 139.9, 141.3, 167.9, 168.1. HRMS (ESI) Calcd for 
C31H26N2NaO3 ([M+Na]+) 497.1836, Found 497.1837. 
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(+)-N-((1-benzyl-5-methoxy-1H-indol-3-yl)(phenyl)methyl)benzamide (105n) 
Following the general procedure, the product  was obtained  as a white solid in 95% yield 
and 98% ee.. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 90/10, 1.0 mL/min), t r-
major 25.75 min, t r-minor 30.35 min. [α]25D = 56.1º (c = 1.0, CHCl3). Mp = 176.8-177.9 ºC. 
IR(solid, cm-1): 3327, 3051, 2930, 1640, 1523, 1486, 1343, 1269, 1207, 1052, 747, 699. 
1H NMR (500MHz, CDCl3): δ 3.76 (s, 3H), 5.23 (s, 2H), 6.74 (d, J = 6.6 Hz, 2H),  6.80 
(d, J = 7.8 Hz, 1H),  6.86 (m, 1H),  7.03 (d, J = 2.0 Hz, 1H), 7.10 (d, J = 6.8 Hz, 2H),  
7.16 (d, J = 8.7 Hz, 1H), 7.32 (m, 3H), 7.41 (m, 5H), 7.51 (m, 3H), 7.84 (m, 2H). 13C 
NMR (125MHz, CDCl3): δ 50.6, 51.1, 56.0, 101.3, 111.3, 113.0, 116.2, 126.9, 127.3, 
127.3, 127.5, 127.6, 127.9, 128.6, 128.8, 128.9, 129.0, 131.8, 132.5, 134.7, 137.6, 141.5, 
154.5, 166.9. HRMS (ESI) Calcd for C30H27N2O2 ([M+H]+) 447.2067, Found 447.2067. 
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(+)-N-((1-benzyl-7-methyl-1H-indol-3-yl)(phenyl)methyl)benzamide (137o) 
Following the general procedure, the product  was obtained  as a white solid in 98% yield 
and 96% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 85/15, 1.0 mL/min), t r-
major 13.32 min, t r-minor 19.85 min. [α]25D = 84.3º (c = 1.1, CHCl3). Mp = 214.0-215.4 ºC. 
IR(solid, cm-1): 3326, 3074, 2971, 1629, 1526, 1490, 1449, 1352, 1303, 1169, 785, 770, 
703, 623. 1H NMR (500MHz, CDCl3): δ  2.53 (s, 3H), 5.52 (s, 2H), 6.71 (s, 1H), 6.79 (m, 
2H), 6.94 (t, J = 7.8 Hz, 3H), 7.03 (t, J = 6.8 Hz, 1H), 7.25-7.53 (m, 12H), 7.84 (d, J = 
8.3 Hz, 2H).  13C NMR (125MHz, CDCl3): δ 19.6, 51.0, 52.4, 116.6, 117.8, 120.5, 121.7, 
125.5, 125.6, 127.3, 127.3, 127.5, 127.6, 128.0, 128.8, 128.8, 129.1, 129.9, 131.8, 134.7, 
136.2, 139.6, 141.6, 166.8. HRMS (ESI) Calcd for C30H26N2NaO ([M+Na]+) 453.1937, 
Found 453.1938. 
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(+)-N-((1-benzyl-2-methyl-1H-indol-3-yl)(phenyl)methyl)benzamide (137p) 
Following the general procedure, the product  was obtained  as a white solid in 91% yield 
and 64% ee. HPLC analysis: Chiralcel OD-H (hexane/iPrOH = 85/15, 1.0 mL/min), t r-
major 11.79 min, t r-minor 17.67 min. [α]25D = 81.2º (c = 1.0, CHCl3). Mp = 76.2-77.3 ºC. 
IR(solid, cm-1): 3374, 3027, 2925, 1640, 1579, 1479, 1341, 1028, 737, 714, 695. 1H NMR 
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(500MHz, CDCl3): δ 2.49 (s, 3H), 5.37 (s, 2H), 6.85 (d, J = 7.3 Hz, 1H), 6.96 (d, J = 7.8 
Hz, 1H), 7.03 (m, 3H), 7.14 (t, J = 6.8 Hz, 1H), 7.25-7.36 (m,  8H), 7.43-7.54 (m, 6H), 
7.86 (d, J = 6.8 Hz, 2H).13C NMR (125MHz, CDCl3): δ 11.0, 47.0, 50.3, 109.9, 111.8, 
118.0, 120.0, 121.5, 126.3, 126.9, 127.2, 127.3, 127.7, 128.7, 128.9, 129.1, 131.8, 134.7, 
135.3, 137.3, 137.7, 141.7, 166.9. HRMS (ESI) Calcd for C30H26N2NaO ([M+Na]+) 
453.1937, Found 453.1939. 
 
 
 
N
HN
O
O
Ph
OMe
 
tert-butyl (1-benzyl-1H-indol-3-yl)(4-methoxyphenyl)methylcarbamate white solid. 
HPLC analysis: Chiralcel AD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 9.17 min, t 
r-minor 19.21 min. Mp = 194.8-195.2 ºC. IR(solid, cm-1): 3391, 3030, 2964, 1675, 1508, 
1390, 1241, 1164, 1028, 813, 742, 726, 635. 1H NMR (500MHz, CDCl3): δ 1.49 (s, 9H), 
3.83 (s, 3H), 5.26 (d, J = 3.4 Hz, 2H), 6.22 (s, 1H), 6.78 (s, 1H), 6.91 (d, J = 8.8 Hz , 2H), 
7.12 (m, 3H), 7.21 (t, J = 8.3 Hz, 1H), 7.26-7.37 (m, 7H,), 7.54 (d, J = 7.8 Hz, 1H). 13C 
NMR (125MHz, CDCl3): δ 28.7, 50.3, 51.4, 55.5, 79.7, 110.2, 114.0, 119.8, 120.1, 122.4, 
126.9, 127.5, 127.8, 128.1, 128.3, 128.9, 129.0, 137.4, 137.6, 155.4, 158.9. HRMS (ESI) 
Calcd for C28H30N2NaO3 ([M+Na]+) 465.2149, Found 465.2145. 
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N-((1H-indol-3-yl)(phenyl)methyl)benzamide white solid. HPLC analysis: Chiralcel 
OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 7.64 min, t r-minor 9.53 min. Mp = 
189.1-190.2 ºC. IR(solid, cm-1): 3385, 3295, 3053, 1607, 1529, 1490, 1337, 735, 698. 1H 
NMR (500MHz, CDCl3): δ 6.75 (d, J =7.8 Hz, 1H), 6.80 (d, J = 8.3 Hz, 2H), 7.12 (t, J = 
7.8 Hz, 1H), 7.24 (t, J = 8.3 Hz, 1H), 7.28-7.59 (m, 10H), 7.83 (d, J = 8.3 Hz, 2H), 8.24 
(s, 1H). 13C NMR (125MHz, CDCl3): δ 51.2, 111.7, 117.5, 119.6, 120.3, 122.8, 124.0, 
126.3, 127.3, 127.3, 127.6, 128.8, 128.9, 131.8, 134.6, 137.0, 141.5, 166.8. HRMS (ESI) 
Calcd for C22H18N2NaO ([M+Na]+) 349.1311, Found 349.1321. 
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N-((1-methyl-1H-indol-3-yl)(phenyl)methyl)benzamide  white solid. HPLC analysis: 
Chiralcel OD-H (hexane/iPrOH = 80/20, 1.0 mL/min), t r-major 8.41 min, t r-minor 9.47 min. 
Mp = 189.7-191.2 ºC. IR(solid, cm-1): 3385, 3295, 3053, 1607, 1529, 1490, 1337, 735, 
698. 1H NMR (500MHz, CDCl3): δ 3.74 (s, 3H), 6.68 (s, 1H), 6.74 (d, J = 7.8 Hz, 1H), 
6.78 (d, J = 7.3, 1H), 7.13 (t, J = 7.8 Hz, 1H), 7.24-7.59 (m, 11H), 7.86 (d, J = 8.3 Hz, 
2H). 13C NMR (125MHz, CDCl3): δ  33.0, 51.1, 109.8, 116.0, 119.7, 119.9, 122.4, 126.7, 
127.2, 127.5, 127.6, 128.8, 128.8, 129.0, 131.8, 134.6, 137.8, 141.7, 166.7. HRMS (ESI) 
Calcd for C23H20N2NaO ([M+Na]+) 363.1468, Found 363.1462. 
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4.2.3.  X-Ray Crystallographic Data 
Table 1.  Crystal data and structure refinement for grpcl1. 
Identification code  grpcl1 
Empirical formula  C29 H23 Cl N2 O 
Formula weight  450.94 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 4.9615(15) Å a= 90°. 
 b = 9.864(3) Å b= 90°. 
 c = 46.603(15) Å g = 90°. 
Volume 2280.7(12) Å3 
Z 4 
Density (calculated) 1.313 Mg/m3 
Absorption coefficient 0.192 mm-1 
F(000) 944 
Crystal size 0.80 x 0.06 x 0.05 mm3 
Theta range for data collection 0.87 to 26.58°. 
Index ranges -5<=h<=6, -6<=k<=12, -56<=l<=58 
Reflections collected 13342 
Independent reflections 4748 [R(int) = 0.0624] 
Completeness to theta = 26.58° 99.7 %  
Absorption correction SADABS 
Max. and min. transmission 1.000 and 0.727 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4748 / 0 / 298 
Goodness-of-fit on F2 1.167 
Final R indices [I>2sigma(I)] R1 = 0.0737, wR2 = 0.1512 
R indices (all data) R1 = 0.0912, wR2 = 0.1628 
Absolute structure parameter 0.09(14) 
Largest diff. peak and hole 0.337 and -0.385 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) 
for grpcl1.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_______________________________________________________________________ 
 x y z U(eq) 
_______________________________________________________________________  
Cl(1) -345(3) 7980(1) 1690(1) 37(1) 
O(1) 6540(5) 937(3) 1789(1) 21(1) 
N(1) 2203(6) 1432(3) 1688(1) 13(1) 
N(2) -1107(7) 369(3) 868(1) 14(1) 
C(1) 640(10) 6317(4) 1603(1) 25(1) 
C(2) -827(9) 5623(4) 1399(1) 23(1) 
C(3) -83(9) 4295(4) 1337(1) 21(1) 
C(4) 2011(9) 3673(4) 1478(1) 15(1) 
C(5) 3455(9) 4413(4) 1681(1) 21(1) 
C(6) 2782(10) 5745(4) 1743(1) 24(1) 
C(7) 2771(8) 2195(4) 1427(1) 14(1) 
C(8) 4132(8) 945(4) 1859(1) 14(1) 
C(9) 3266(8) 418(4) 2145(1) 13(1) 
C(10) 4637(9) -647(4) 2273(1) 23(1) 
C(11) 3912(9) -1092(4) 2542(1) 25(1) 
C(12) 1865(9) -455(4) 2692(1) 22(1) 
C(13) 547(9) 628(4) 2573(1) 22(1) 
C(14) 1209(8) 1054(4) 2298(1) 19(1) 
C(15) 1510(8) 1572(4) 1165(1) 12(1) 
C(16) 2246(8) 1901(4) 874(1) 13(1) 
C(17) 4154(8) 2762(4) 750(1) 14(1) 
C(18) 4384(9) 2809(4) 457(1) 19(1) 
C(19) 2711(8) 2013(5) 280(1) 17(1) 
C(20) 800(8) 1165(4) 395(1) 15(1) 
C(21) 556(9) 1124(4) 694(1) 16(1) 
C(22) -532(8) 661(4) 1151(1) 15(1) 
C(23) -3178(8) -561(4) 763(1) 18(1) 
C(24) -2078(8) -1846(4) 633(1) 16(1) 
C(25) 7(10) -2566(4) 761(1) 27(1) 
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C(26) 874(10) -3766(5) 641(1) 34(1) 
C(27) -277(10) -4269(5) 395(1) 35(1) 
C(28) -2312(10) -3542(5) 261(1) 31(1) 
C(29) -3219(10) -2342(5) 385(1) 27(1) 
_______________________________________________________________________ 
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 Table 3.   Bond lengths [Å] and angles [°] for  grpcl1. 
_____________________________________________________  
Cl(1)-C(1)  1.760(4) 
O(1)-C(8)  1.239(5) 
N(1)-C(8)  1.336(5) 
N(1)-C(7)  1.459(5) 
N(2)-C(21)  1.376(5) 
N(2)-C(22)  1.379(5) 
N(2)-C(23)  1.461(5) 
C(1)-C(6)  1.370(6) 
C(1)-C(2)  1.379(6) 
C(2)-C(3)  1.391(6) 
C(3)-C(4)  1.375(6) 
C(4)-C(5)  1.393(6) 
C(4)-C(7)  1.525(5) 
C(5)-C(6)  1.385(6) 
C(7)-C(15)  1.501(5) 
C(8)-C(9)  1.493(5) 
C(9)-C(10)  1.386(6) 
C(9)-C(14)  1.393(6) 
C(10)-C(11)  1.374(5) 
C(11)-C(12)  1.384(6) 
C(12)-C(13)  1.370(6) 
C(13)-C(14)  1.388(5) 
C(15)-C(22)  1.356(5) 
C(15)-C(16)  1.444(5) 
C(16)-C(17)  1.397(5) 
C(16)-C(21)  1.412(5) 
C(17)-C(18)  1.370(5) 
C(18)-C(19)  1.408(6) 
C(19)-C(20)  1.372(6) 
C(20)-C(21)  1.397(5) 
C(23)-C(24)  1.509(6) 
C(24)-C(29)  1.375(6) 
C(24)-C(25)  1.390(6) 
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C(25)-C(26)  1.377(6) 
C(26)-C(27)  1.374(7) 
C(27)-C(28)  1.388(7) 
C(28)-C(29)  1.392(6) 
 
C(8)-N(1)-C(7) 123.1(3) 
C(21)-N(2)-C(22) 109.1(3) 
C(21)-N(2)-C(23) 124.4(3) 
C(22)-N(2)-C(23) 126.5(3) 
C(6)-C(1)-C(2) 122.3(4) 
C(6)-C(1)-Cl(1) 119.2(3) 
C(2)-C(1)-Cl(1) 118.5(4) 
C(1)-C(2)-C(3) 118.1(4) 
C(4)-C(3)-C(2) 121.4(4) 
C(3)-C(4)-C(5) 118.7(4) 
C(3)-C(4)-C(7) 122.5(4) 
C(5)-C(4)-C(7) 118.7(4) 
C(6)-C(5)-C(4) 121.0(4) 
C(1)-C(6)-C(5) 118.5(4) 
N(1)-C(7)-C(15) 112.7(3) 
N(1)-C(7)-C(4) 108.3(3) 
C(15)-C(7)-C(4) 114.6(3) 
O(1)-C(8)-N(1) 122.4(3) 
O(1)-C(8)-C(9) 120.7(4) 
N(1)-C(8)-C(9) 116.9(3) 
C(10)-C(9)-C(14) 118.8(4) 
C(10)-C(9)-C(8) 120.4(4) 
C(14)-C(9)-C(8) 120.6(4) 
C(11)-C(10)-C(9) 120.4(4) 
C(10)-C(11)-C(12) 120.5(4) 
C(13)-C(12)-C(11) 120.0(4) 
C(12)-C(13)-C(14) 119.9(4) 
C(13)-C(14)-C(9) 120.5(4) 
C(22)-C(15)-C(16) 106.9(3) 
C(22)-C(15)-C(7) 128.6(3) 
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C(16)-C(15)-C(7) 124.5(3) 
C(17)-C(16)-C(21) 119.1(3) 
C(17)-C(16)-C(15) 134.2(3) 
C(21)-C(16)-C(15) 106.7(3) 
C(18)-C(17)-C(16) 119.3(4) 
C(17)-C(18)-C(19) 120.9(4) 
C(20)-C(19)-C(18) 121.3(3) 
C(19)-C(20)-C(21) 117.8(4) 
N(2)-C(21)-C(20) 130.9(4) 
N(2)-C(21)-C(16) 107.4(3) 
C(20)-C(21)-C(16) 121.6(4) 
C(15)-C(22)-N(2) 109.9(3) 
N(2)-C(23)-C(24) 114.0(3) 
C(29)-C(24)-C(25) 119.1(4) 
C(29)-C(24)-C(23) 119.2(4) 
C(25)-C(24)-C(23) 121.7(4) 
C(26)-C(25)-C(24) 119.8(4) 
C(27)-C(26)-C(25) 121.2(5) 
C(26)-C(27)-C(28) 119.5(4) 
C(27)-C(28)-C(29) 119.1(4) 
C(24)-C(29)-C(28) 121.2(5) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
94 
 Table 4.   Anisotropic displacement parameters  (Å2x 103) for grpcl1.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
_______________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________________ 
Cl(1) 64(1)  14(1) 32(1)  -4(1) 8(1)  4(1) 
O(1) 9(2)  35(2) 20(1)  7(1) 1(1)  1(1) 
N(1) 8(2)  17(2) 13(1)  3(1) 3(1)  0(1) 
N(2) 12(2)  16(2) 15(1)  -3(1) 1(1)  -3(2) 
C(1) 41(3)  15(2) 18(2)  -1(2) 18(2)  -4(2) 
C(2) 24(2)  24(2) 21(2)  1(2) -4(2)  6(2) 
C(3) 18(2)  25(2) 20(2)  -4(2) -2(2)  -3(2) 
C(4) 17(2)  16(2) 13(2)  3(2) 5(2)  -2(2) 
C(5) 20(2)  24(2) 18(2)  -5(2) 2(2)  1(2) 
C(6) 37(3)  22(2) 14(2)  -7(2) 3(2)  -5(2) 
C(7) 11(2)  15(2) 16(2)  -3(2) 4(2)  -1(2) 
C(8) 12(2)  16(2) 14(2)  -3(1) 0(2)  -3(2) 
C(9) 11(2)  15(2) 12(2)  0(2) -4(2)  -3(2) 
C(10) 19(2)  26(2) 24(2)  5(2) 1(2)  4(2) 
C(11) 25(3)  19(2) 30(2)  11(2) -7(2)  1(2) 
C(12) 24(2)  28(2) 13(2)  7(2) -3(2)  -9(2) 
C(13) 19(2)  26(2) 20(2)  -4(2) 5(2)  -3(2) 
C(14) 21(2)  20(2) 15(2)  -3(2) -3(2)  4(2) 
C(15) 16(2)  8(2) 12(2)  1(1) 0(2)  0(2) 
C(16) 12(2)  14(2) 12(2)  -5(2) -1(2)  5(2) 
C(17) 11(2)  16(2) 16(2)  -3(2) -3(2)  1(2) 
C(18) 19(2)  18(2) 18(2)  -2(2) -2(2)  2(2) 
C(19) 14(2)  25(2) 13(2)  1(2) 2(2)  1(2) 
C(20) 13(2)  18(2) 14(2)  -3(2) -2(2)  3(2) 
C(21) 16(2)  12(2) 21(2)  -1(2) 0(2)  10(2) 
C(22) 17(2)  14(2) 15(2)  -1(2) 3(2)  0(2) 
C(23) 15(2)  18(2) 20(2)  -3(2) 4(2)  -6(2) 
C(24) 13(2)  18(2) 18(2)  -2(2) 4(2)  -3(2) 
C(25) 28(3)  24(2) 30(2)  2(2) 1(2)  2(2) 
C(26) 26(3)  23(2) 52(3)  1(2) 4(2)  4(2) 
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C(27) 34(3)  23(2) 46(3)  -15(2) 17(2)  -5(2) 
C(28) 31(3)  33(3) 29(2)  -19(2) 6(2)  -11(2) 
C(29) 24(3)  28(3) 28(2)  -5(2) -1(2)  -7(2) 
_______________________________________________________________________ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 
3) 
for grpcl1. 
_______________________________________________________________________ 
 x  y  z  U(eq) 
_______________________________________________________________________ 
  
H(1N) 415 1401 1746 19 
H(2) -2302 6039 1303 28 
H(3) -1043 3807 1194 25 
H(5) 4922 3999 1778 25 
H(6) 3785 6250 1880 29 
H(7) 4803 2085 1388 21 
H(10) 6085 -1072 2175 28 
H(11) 4823 -1842 2625 30 
H(12) 1373 -768 2877 26 
H(13) -816 1086 2678 26 
H(14) 251 1786 2213 22 
H(17) 5281 3309 867 17 
H(18) 5690 3387 372 22 
H(19) 2908 2063 78 21 
H(20) -318 625 276 18 
H(22) -1433 280 1311 18 
H(23A) -4294 11 627 27 
H(23B) -4388 -695 906 27 
H(25) 832 -2231 931 33 
H(26) 2294 -4255 731 40 
H(27) 316 -5108 318 42 
H(28) -3076 -3859 86 37 
H(29) -4653 -1857 297 32 
_______________________________________________________________________
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 Table 6.  Torsion angles [°] for grpcl1. 
________________________________________________________________  
C(6)-C(1)-C(2)-C(3) 0.2(6) 
Cl(1)-C(1)-C(2)-C(3) -178.1(3) 
C(1)-C(2)-C(3)-C(4) 1.4(6) 
C(2)-C(3)-C(4)-C(5) -2.0(6) 
C(2)-C(3)-C(4)-C(7) 176.5(4) 
C(3)-C(4)-C(5)-C(6) 0.9(6) 
C(7)-C(4)-C(5)-C(6) -177.7(4) 
C(2)-C(1)-C(6)-C(5) -1.3(6) 
Cl(1)-C(1)-C(6)-C(5) 177.0(3) 
C(4)-C(5)-C(6)-C(1) 0.7(6) 
C(8)-N(1)-C(7)-C(15) 123.4(4) 
C(8)-N(1)-C(7)-C(4) -108.8(4) 
C(3)-C(4)-C(7)-N(1) -113.2(4) 
C(5)-C(4)-C(7)-N(1) 65.3(4) 
C(3)-C(4)-C(7)-C(15) 13.6(5) 
C(5)-C(4)-C(7)-C(15) -167.9(3) 
C(7)-N(1)-C(8)-O(1) -10.3(6) 
C(7)-N(1)-C(8)-C(9) 168.8(3) 
O(1)-C(8)-C(9)-C(10) -32.8(6) 
N(1)-C(8)-C(9)-C(10) 148.0(4) 
O(1)-C(8)-C(9)-C(14) 142.1(4) 
N(1)-C(8)-C(9)-C(14) -37.1(5) 
C(14)-C(9)-C(10)-C(11) 2.1(6) 
C(8)-C(9)-C(10)-C(11) 177.1(4) 
C(9)-C(10)-C(11)-C(12) -2.1(7) 
C(10)-C(11)-C(12)-C(13) -0.1(7) 
C(11)-C(12)-C(13)-C(14) 2.2(6) 
C(12)-C(13)-C(14)-C(9) -2.1(6) 
C(10)-C(9)-C(14)-C(13) 0.0(6) 
C(8)-C(9)-C(14)-C(13) -175.0(4) 
N(1)-C(7)-C(15)-C(22) 18.3(6) 
C(4)-C(7)-C(15)-C(22) -106.1(5) 
N(1)-C(7)-C(15)-C(16) -164.3(3) 
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C(4)-C(7)-C(15)-C(16) 71.3(5) 
C(22)-C(15)-C(16)-C(17) 179.6(4) 
C(7)-C(15)-C(16)-C(17) 1.7(7) 
C(22)-C(15)-C(16)-C(21) -0.8(4) 
C(7)-C(15)-C(16)-C(21) -178.6(4) 
C(21)-C(16)-C(17)-C(18) -1.5(6) 
C(15)-C(16)-C(17)-C(18) 178.1(4) 
C(16)-C(17)-C(18)-C(19) 0.6(6) 
C(17)-C(18)-C(19)-C(20) 0.0(7) 
C(18)-C(19)-C(20)-C(21) 0.4(6) 
C(22)-N(2)-C(21)-C(20) 178.2(4) 
C(23)-N(2)-C(21)-C(20) -3.2(6) 
C(22)-N(2)-C(21)-C(16) 0.7(4) 
C(23)-N(2)-C(21)-C(16) 179.3(3) 
C(19)-C(20)-C(21)-N(2) -178.6(4) 
C(19)-C(20)-C(21)-C(16) -1.4(6) 
C(17)-C(16)-C(21)-N(2) 179.7(3) 
C(15)-C(16)-C(21)-N(2) 0.0(4) 
C(17)-C(16)-C(21)-C(20) 1.9(6) 
C(15)-C(16)-C(21)-C(20) -177.8(4) 
C(16)-C(15)-C(22)-N(2) 1.2(4) 
C(7)-C(15)-C(22)-N(2) 179.0(4) 
C(21)-N(2)-C(22)-C(15) -1.2(4) 
C(23)-N(2)-C(22)-C(15) -179.8(4) 
C(21)-N(2)-C(23)-C(24) 72.3(5) 
C(22)-N(2)-C(23)-C(24) -109.4(4) 
N(2)-C(23)-C(24)-C(29) -138.2(4) 
N(2)-C(23)-C(24)-C(25) 43.8(5) 
C(29)-C(24)-C(25)-C(26) -0.8(6) 
C(23)-C(24)-C(25)-C(26) 177.2(4) 
C(24)-C(25)-C(26)-C(27) 0.3(7) 
C(25)-C(26)-C(27)-C(28) 1.4(7) 
C(26)-C(27)-C(28)-C(29) -2.5(7) 
C(25)-C(24)-C(29)-C(28) -0.4(6) 
C(23)-C(24)-C(29)-C(28) -178.4(4) 
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C(27)-C(28)-C(29)-C(24) 2.1(7) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 Table 7.  Hydrogen bonds for grpcl1  [Å and °]. 
_______________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
_______________________________________________________________________  
 N(1)-H(1N)...O(1)#1 0.93 1.99 2.890(4) 164.2 
_______________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x-1,y,z       
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Chapter 5 
1H and 13C Spectra for Compound 
5.1. 1H and 13C Spectra for Compounds in Chapter 2 
Spectra 5.1.1. 1H and 13C Spectra for Compound 105a 
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Spectra 5.1.2 1H and 13C Spectra for Compound 105b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
103 
Spectra 5.1.3. 1H and 13C Spectra for Compound 105c 
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Spectra 5.1.4. 1H and 13C Spectra for Compound 105d 
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Spectra 5.1.5. 1H and 13C Spectra for Compound 105e 
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Spectra 5.1.6. 1H and 13C Spectra for Compound 105f 
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Spectra 5.1.7. 1H and 13C Spectra for Compound 105g 
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Spectra 5.1.8. 1H and 13C Spectra for Compound 105h 
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Spectra 5.1.9. 1H and 13C Spectra for Compound 105i 
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Spectra 5.1.10. 1H and 13C Spectra for Compound 105j 
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 Spectra 5.1.11. 1H and 13C Spectra for Compound 105k 
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Spectra 5.1.12. 1H and 13C Spectra for Compound 105l 
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Spectra 5.1.13. 1H and 13C Spectra for Compound 105m 
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Spectra Spectra 5.1.15. 1H and 13C Spectra for Compound 105o 
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Spectra 5.1.16. 1H and 13C Spectra for Compound 105p 
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Spectra 5.1.17. 1H and 13C Spectra for Compound 105q 
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Spectra 5.1.18. 1H and 13C Spectra for Compound 105r 
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Spectra 5.1.19.  1H and 13C Spectra for Compound 105s 
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Spectra 5.1.20.  1H and 13C Spectra for Compound 105t 
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Spectra 5.1.21. 1H and 13C Spectra for Compound 105u 
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Spectra 5.1.22. 1H and 13C Spectra for Compound 105v 
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Spectra 5.1.23. 1H and 13C Spectra for Compound 105w 
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5.2. 1H and 13C Spectra for Compounds in Chapter 3 
Spectra 5.2.1 1H and 13C Spectra for Compound 137a 
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Spectra 5.2.5. 1H and 13C Spectra for Compound 137b 
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Spectra 5.2.2. 1H and 13C Spectra for Compound 137c 
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Spectra 5.2.3. 1H and 13C Spectra for Compound 137d 
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Spectra 5.2.4. 1H and 13C Spectra for Compound 137e 
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Spectra 5.2.6. 1H and 13C Spectra for Compound 137f 
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Spectra 5.2.7. 1H and 13C Spectra for Compound 137g 
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S Spectra 5.2.8. 1H and 13C Spectra for Compound 137h 
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Spectra 5.2.9. 1H and 13C Spectra for Compound 137i 
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Spectra 5.2.10. 1H and 13C Spectra for Compound 137j 
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Spectra 5.2.11. 1H and 13C Spectra for Compound 137k 
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Spectra 5.2.12. 1H and 13C Spectra for Compound 137l 
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Spectra 5.2.13. 1H and 13C Spectra for Compound 137m 
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Spectra 5.2.14. 1H and 13C Spectra for Compound 137n 
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Spectra 5.2.15. 1H and 13C Spectra for Compound 130o 
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Spectra 5.2.16. 1H and 13C Spectra for Compound 130p 
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